_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
724993110,5/22/2015 17:32:11,1641446109,5/22/2015 17:31:58,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combination,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 17:42:35,1641452929,5/22/2015 17:42:25,false,elite,1,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combination,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 17:52:09,1641459037,5/22/2015 17:51:44,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],two in combination,n/a,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 17:55:49,1641462111,5/22/2015 17:55:37,false,elite,1,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combination,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 17:57:22,1641463450,5/22/2015 17:57:08,false,instagc,1,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],CHONDROITIN SULFATE for painful knee OSTEOARTHRITIS,n/a,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 17:59:18,1641465468,5/22/2015 17:58:42,false,neodev,1,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],and,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:04:56,1641471068,5/22/2015 18:04:47,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CHONDROITIN SULFATE and the two in combination,n/a,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:08:01,1641473651,5/22/2015 18:07:08,false,neodev,1,31294288,USA,IL,Chicago,67.212.188.11,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",in combination for painful knee,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:15:49,1641482035,5/22/2015 18:14:35,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],in,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:17:40,1641484004,5/22/2015 18:17:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CHONDROITIN SULFATE for OSTEOARTHRITIS,na,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:17:50,1641484134,5/22/2015 18:17:22,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for painful knee,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:18:51,1641485198,5/22/2015 18:18:29,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],CHONDROITIN SULFATE for painful knee OSTEOARTHRITIS,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:22:11,1641488652,5/22/2015 18:20:29,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],for painful,none,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:28:24,1641495649,5/22/2015 18:27:58,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],the two in combination,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993110,5/22/2015 18:34:39,1641502497,5/22/2015 18:33:25,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,150,86,-1,163,105,TWrex-cause,800405-FS1,"1]  Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, CHONDROITIN SULFATE and the two in combination for painful knee OSTEOARTHRITIS",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993111,5/22/2015 18:27:05,1641494132,5/22/2015 18:26:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as initial treatment for,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 18:27:33,1641494625,5/22/2015 18:27:09,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],PEGYLATED INTERFERON ALFA 2B treatment CHRONIC HEPATITIS C,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 18:38:02,1641505920,5/22/2015 18:37:45,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],treatment,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 18:49:02,1641517116,5/22/2015 18:48:28,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 18:49:58,1641518259,5/22/2015 18:49:15,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [IS_A],"[TREATS]
[IS_A]",A treatment,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 18:53:42,1641521899,5/22/2015 18:53:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],PEGYLATED INTERFERON ALFA 2B initial treatment for CHRONIC HEPATITIS C,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 18:58:47,1641527112,5/22/2015 18:58:09,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",comparing PEGYLATED INTERFERON ALFA 2B interferon alfa 2b treatment CHRONIC HEPATITIS C,na,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 19:03:30,1641532455,5/22/2015 19:03:19,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 19:05:23,1641534753,5/22/2015 19:04:50,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment for,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 19:36:28,1641583562,5/22/2015 19:35:59,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment for,n/a,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 19:46:06,1641595156,5/22/2015 19:45:50,false,bitcoinget,1,31947120,USA,CA,El Monte,198.101.125.188,[TREATS],[TREATS],treatment,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 19:48:44,1641598362,5/22/2015 19:48:25,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],as initial treatment,n/a,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 19:54:10,1641605802,5/22/2015 19:53:21,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,n/a,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 20:17:25,1641639656,5/22/2015 20:16:54,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treatment for,N/A,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993111,5/22/2015 20:20:46,1641644421,5/22/2015 20:19:53,false,neodev,1.0,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,158,82,-1,176,110,TWrex-cause,800449-FS1,"Lindsay KL, Trepo C, Heintges T et al. A randomized, double blind trial comparing PEGYLATED INTERFERON ALFA 2B to interferon alfa 2b as initial treatment for CHRONIC HEPATITIS C",CHRONIC HEPATITIS C,PEGYLATED INTERFERON ALFA 2B
724993112,5/22/2015 16:43:02,1641414213,5/22/2015 16:42:48,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],occurs,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:48:22,1641418092,5/22/2015 16:47:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],PAIN occurs,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:48:46,1641418413,5/22/2015 16:47:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"Trigeminal Neuralgia (Tic Douloureux) Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",n/a,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:49:24,1641418936,5/22/2015 16:48:22,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],in which occurs,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:51:56,1641420925,5/22/2015 16:50:23,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],is a distinctive facial pain,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:53:20,1641421703,5/22/2015 16:52:40,false,neodev,1,27667288,CAN,MB,Brandon,216.36.154.251,[SYMPTOM],[SYMPTOM],in which occurs several times,n/a,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:54:36,1641422652,5/22/2015 16:54:00,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or is a of of,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:55:44,1641423524,5/22/2015 16:55:19,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],facial pain,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 16:57:31,1641424767,5/22/2015 16:57:16,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],facial pain,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 17:00:40,1641426887,5/22/2015 16:59:31,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[PART_OF],[PART_OF],"in which intense, PAROXYSMAL PAIN occurs several times",N/a,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 17:07:39,1641431120,5/22/2015 17:07:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],is a distinctive facial pain syndrome of,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 17:08:29,1641431670,5/22/2015 17:07:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],"which intense, PAROXYSMAL PAIN occurs several times",N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 17:11:08,1641433634,5/22/2015 17:10:56,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],facial pain,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 17:11:11,1641433650,5/22/2015 17:10:53,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],occurs,n/a,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993112,5/22/2015 17:11:43,1641433936,5/22/2015 17:11:16,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or is a of of,N/A,170,64,1,184,78,TWrex-cause,812825-FS1,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX
724993113,5/22/2015 16:39:12,1641411309,5/22/2015 16:38:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years,n/a,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:39:49,1641411836,5/22/2015 16:39:14,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:39:57,1641411920,5/22/2015 16:37:41,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:42:16,1641413586,5/22/2015 16:41:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:43:13,1641414340,5/22/2015 16:41:51,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],reduces,n/a,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:43:46,1641414755,5/22/2015 16:43:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:46:15,1641416465,5/22/2015 16:45:32,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:50:40,1641420015,5/22/2015 16:50:17,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/a,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:51:47,1641420828,5/22/2015 16:51:01,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ENDOMETRIOSIS,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:53:59,1641422220,5/22/2015 16:53:17,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 16:55:07,1641423066,5/22/2015 16:54:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 17:00:45,1641426945,5/22/2015 17:00:04,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],reduces,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 17:05:44,1641429818,5/22/2015 17:04:36,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 17:07:09,1641430860,5/22/2015 17:06:32,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993113,5/22/2015 17:08:00,1641431327,5/22/2015 17:06:49,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"PAIN associated with END<span id=""transmark""></span>OMETRIOSIS",n/a,82,103,1,85,116,TWrex-cause,813518-FS1,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS
724993114,5/22/2015 16:42:04,1641413419,5/22/2015 16:41:45,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],infection,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:45:42,1641416267,5/22/2015 16:44:52,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"INFECTIVE ENDOCARDITIS INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",n/a,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:46:24,1641416632,5/22/2015 16:45:41,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],infection,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:47:00,1641417154,5/22/2015 16:46:28,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],infection of,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:49:49,1641419275,5/22/2015 16:49:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],usually with,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:51:17,1641420377,5/22/2015 16:49:37,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],usually with,n/a,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:52:46,1641421326,5/22/2015 16:52:13,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is of with or,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:54:44,1641422800,5/22/2015 16:54:17,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],BACTERIA,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:56:12,1641423797,5/22/2015 16:55:53,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],infection,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 16:58:29,1641425525,5/22/2015 16:56:23,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[IS_A],[IS_A],"is infection of the endocardium, usually with BACTERIA",N/a,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 17:04:16,1641428910,5/22/2015 17:03:24,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],usually with,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 17:06:34,1641430344,5/22/2015 17:06:19,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],infection,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 17:09:31,1641432472,5/22/2015 17:09:15,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],infection,N/A,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 17:10:21,1641433042,5/22/2015 17:09:56,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],is,n/a,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993114,5/22/2015 17:11:55,1641434099,5/22/2015 17:10:58,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],INFECTIVE ENDOCARDITIS is infection with BACTERIA,n/a,0,93,1,21,101,TWrex-cause,810847-FS1,"INFECTIVE ENDOCARDITIS  INFECTIVE ENDOCARDITIS is infection of the endocardium, usually with BACTERIA (commonly, streptococci and staphylococci) or fungi.",INFECTIVE ENDOCARDITIS,BACTERIA
724993115,5/22/2015 17:27:26,1641443828,5/22/2015 17:27:11,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:40:22,1641451342,5/22/2015 17:40:09,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:44:29,1641454216,5/22/2015 17:44:08,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:45:42,1641454900,5/22/2015 17:44:51,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treatment,n/a,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:51:21,1641458327,5/22/2015 17:50:38,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],alDHPG treatment of kidney recipients with severe CMV INFECTION,n/a,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:52:46,1641459462,5/22/2015 17:52:36,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:54:57,1641461267,5/22/2015 17:54:43,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:56:54,1641463040,5/22/2015 17:56:18,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],treatment of kidney transplant,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 17:59:47,1641465948,5/22/2015 17:59:35,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],kidney transplant recipients,n/a,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 18:09:12,1641474817,5/22/2015 18:08:43,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",treatment of with,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 18:10:18,1641475970,5/22/2015 18:09:42,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alDHPG treatment of severe CMV INFECTION,na,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 18:11:38,1641477424,5/22/2015 18:11:23,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment of,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 18:13:24,1641479497,5/22/2015 18:12:59,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 18:13:44,1641479889,5/22/2015 18:13:15,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],alDHPG treatment CMV INFECTION,N/A,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993115,5/22/2015 18:15:44,1641481779,5/22/2015 18:14:17,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS] [SYMPTOM],"[TREATS]
[SYMPTOM]",alDHPG CMV INFECTION,n/a,94,35,-1,106,39,TWrex-cause,800728-FS1,"Lang P, Buisson C, Rostoker G et alDHPG treatment of kidney transplant recipients with severe CMV INFECTION",CMV INFECTION,DHPG
724993116,5/22/2015 16:48:20,1641418030,5/22/2015 16:47:36,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],"syndrome,",N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 16:54:17,1641422455,5/22/2015 16:53:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],varieties of,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 16:56:41,1641424189,5/22/2015 16:56:23,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:01:24,1641427518,5/22/2015 17:00:18,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",n/a,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:01:45,1641427700,5/22/2015 17:01:26,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],synthetic,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:02:02,1641427836,5/22/2015 17:01:00,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of is,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:03:18,1641428615,5/22/2015 17:02:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],HERMANSKY PUDLAK SYNDROME,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:03:25,1641428692,5/22/2015 17:02:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],varieties,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:11:52,1641434062,5/22/2015 17:11:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],primary defect,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:14:46,1641436021,5/22/2015 17:14:32,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],include,n/a,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:15:10,1641436343,5/22/2015 17:14:04,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],synthetic,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:17:04,1641437674,5/22/2015 17:16:29,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of is,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:17:45,1641438014,5/22/2015 17:17:10,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","secondary varieties ALBINISM primary defect not specific melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME 87 Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, Angelman syndrome.",n/a,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:17:56,1641438164,5/22/2015 17:17:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],secondary varieties of,N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993116,5/22/2015 17:18:24,1641438481,5/22/2015 17:17:09,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME",N/A,27,123,1,34,148,TWrex-cause,812829-FS1,"The secondary varieties of ALBINISM in which the primary defect is not specific for the melanin synthetic pathway, include HERMANSKY PUDLAK SYNDROME  87   Chediak Higashi syndrome, Cross McKusick Breen syndrome, Prader Willi syndrome, and Angelman syndrome.",ALBINISM,HERMANSKY PUDLAK SYNDROME
724993117,5/22/2015 18:23:42,1641490242,5/22/2015 18:23:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for suppression of,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:24:12,1641490837,5/22/2015 18:23:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],AMPHOTERICIN B suppression CRYPTOCOCCAL MENINGITIS,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:26:31,1641493554,5/22/2015 18:24:54,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",A of of of,CFsurvey88,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:33:10,1641500805,5/22/2015 18:32:47,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],suppression,none,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:33:44,1641501442,5/22/2015 18:33:27,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],controlled clinical trial,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:45:26,1641513994,5/22/2015 18:44:54,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",A of a of of,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:46:40,1641515179,5/22/2015 18:45:31,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],for suppression of,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:48:46,1641516952,5/22/2015 18:48:15,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],AMPHOTERICIN B for suppression CRYPTOCOCCAL MENINGITIS,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:49:48,1641518092,5/22/2015 18:49:13,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,na,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:53:48,1641522022,5/22/2015 18:52:29,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],for suppression,none,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:56:35,1641524925,5/22/2015 18:54:53,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],for suppression of,n/a,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 18:57:05,1641525428,5/22/2015 18:56:04,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],controlled trial,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 19:01:35,1641530354,5/22/2015 19:01:23,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 19:12:46,1641543682,5/22/2015 19:12:23,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],results,N/A,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993117,5/22/2015 19:33:12,1641579607,5/22/2015 19:32:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for suppression of,n/a,139,105,-1,161,119,TWrex-cause,800927-FS1,A note to physicians: important information on results of a controlled clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B
724993118,5/22/2015 16:45:32,1641416108,5/22/2015 16:45:18,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],cause;,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 16:52:15,1641421074,5/22/2015 16:51:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],characterized by,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 16:54:58,1641422987,5/22/2015 16:54:29,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],characterized by,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 16:56:34,1641424087,5/22/2015 16:55:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Hyperthyroidism during childhood and adolescence: GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",n/a,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 16:58:10,1641425250,5/22/2015 16:57:40,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",is cause; is by,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 16:58:58,1641425793,5/22/2015 16:56:35,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],is characterized,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 16:59:36,1641426222,5/22/2015 16:59:25,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],cause;,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 16:59:59,1641426511,5/22/2015 16:59:21,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],GRAVES' DISEASE,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 17:09:39,1641432580,5/22/2015 17:09:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause;,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 17:12:56,1641434790,5/22/2015 17:12:43,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],cause;,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 17:13:08,1641434891,5/22/2015 17:12:43,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],it is characterized,n/a,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 17:14:09,1641435695,5/22/2015 17:13:37,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],Hyperthyroidism during childhood and adolescence: GRAVES' DISEASE is the usual cause;,n/a,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 17:14:10,1641435699,5/22/2015 17:13:30,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]","GRAVES' DISEASE is characterized by THYROTOX<span id=""transmark""></span>ICOSIS",n/a,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 17:14:32,1641435872,5/22/2015 17:13:44,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],"characterized by diffuse goiter,",N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993118,5/22/2015 17:16:16,1641437138,5/22/2015 17:13:28,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",during is cause; is by,N/A,51,126,1,65,140,TWrex-cause,812907-FS1,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS
724993119,5/22/2015 17:29:30,1641444972,5/22/2015 17:29:14,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],Treatment,N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 17:41:38,1641452185,5/22/2015 17:41:29,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],Treatment,N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 17:49:15,1641456909,5/22/2015 17:49:03,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 17:54:26,1641460875,5/22/2015 17:54:14,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],Treatment,N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 17:55:02,1641461346,5/22/2015 17:54:36,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON),n/a,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 17:57:12,1641463342,5/22/2015 17:56:46,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [PART_OF] [ASSOCIATED_WITH] [IS_A],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",Treatment of with Α a,N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:00:35,1641466668,5/22/2015 17:59:59,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",Treatment of with,N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:03:01,1641469105,5/22/2015 18:02:44,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Treatment of RENAL,n/a,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:12:47,1641478903,5/22/2015 18:12:10,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of with Α a,N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:14:19,1641480640,5/22/2015 18:12:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON),na,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:15:52,1641482074,5/22/2015 18:14:30,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment of,N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:16:29,1641482695,5/22/2015 18:15:55,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[ASSOCIATED_WITH],[ASSOCIATED_WITH],RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON),N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:17:04,1641483330,5/22/2015 18:16:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Treatment,none,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:25:46,1641492687,5/22/2015 18:25:24,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],RENAL CELL CARCINOMA (HUMAN LEUKOCYTE INTERFERON),N/A,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993119,5/22/2015 18:28:11,1641495241,5/22/2015 18:27:47,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],Treatment with,n/a,56,82,-1,75,112,TWrex-cause,804095-FS1,"Figlin RA, deKernlon JB, Maldazys J et al. Treatment of RENAL CELL CARCINOMA with Α (HUMAN LEUKOCYTE INTERFERON) and vinblastine in combination: a phase I II trial.",RENAL CELL CARCINOMA,Α (HUMAN LEUKOCYTE INTERFERON)
724993120,5/22/2015 17:17:14,1641437745,5/22/2015 17:17:03,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:18:06,1641438310,5/22/2015 17:17:56,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:21:22,1641440521,5/22/2015 17:21:10,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:22:25,1641441165,5/22/2015 17:21:34,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],WHOOPING COUGH caused by BORDETELLA PERTUSSIS Bordetella parapertussis,n/a,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:22:46,1641441340,5/22/2015 17:21:56,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",by an,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:22:46,1641441345,5/22/2015 17:22:15,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"WHOOPING COUGH caused by BORDETELLA PERT<span id=""transmark""></span>USSIS",n/a,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:22:55,1641441436,5/22/2015 17:22:37,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:23:22,1641441648,5/22/2015 17:22:32,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],WHOOPING COUGH caused by BORDETELLA PERTUSSIS,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:24:35,1641442333,5/22/2015 17:22:13,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:33:52,1641447114,5/22/2015 17:33:31,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[CAUSES],[CAUSES],caused by,N/a,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:35:10,1641448018,5/22/2015 17:34:58,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:37:47,1641449829,5/22/2015 17:37:15,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[CAUSES],[CAUSES],caused by,n/a,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:38:05,1641450022,5/22/2015 17:37:51,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],WHOOPING COUGH caused by BORDETELLA PERTUSSIS,n/a,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:40:43,1641451546,5/22/2015 17:40:10,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[CAUSES],[CAUSES],caused by,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993120,5/22/2015 17:42:37,1641453011,5/22/2015 17:42:17,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,[CAUSES],[CAUSES],caused by,N/A,60,86,1,73,106,TWrex-cause,810171-FS1,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS
724993121,5/22/2015 18:03:23,1641469453,5/22/2015 18:02:52,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES],[CAUSES],cause,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:20:38,1641487114,5/22/2015 18:20:03,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]",cause of,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:20:49,1641487266,5/22/2015 18:20:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],cause conditions such as,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:21:58,1641488444,5/22/2015 18:21:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],MITES cause MANGE,na,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:22:12,1641488694,5/22/2015 18:21:55,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[CAUSES],[CAUSES],MITES cause MANGE,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:28:24,1641495614,5/22/2015 18:27:20,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:31:28,1641498794,5/22/2015 18:31:11,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[CAUSES],[CAUSES],cause,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:38:04,1641505934,5/22/2015 18:37:34,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:40:12,1641508567,5/22/2015 18:39:45,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],cause MANGE,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:41:39,1641510281,5/22/2015 18:41:18,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES],[CAUSES],cause,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:44:45,1641513311,5/22/2015 18:43:12,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[CAUSES],[CAUSES],cause conditions such as,no,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:45:05,1641513616,5/22/2015 18:44:34,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],Some MITES and cause MANGE,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:46:58,1641515469,5/22/2015 18:46:31,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",MITES parasitic cause conditions MANGE,na,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:47:07,1641515565,5/22/2015 18:46:25,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],"cause asthma, MANGE",n/a,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993121,5/22/2015 18:48:32,1641516763,5/22/2015 18:47:52,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],cause,N/A,62,5,1,66,10,TWrex-cause,810052-FS1,"Some MITES are parasitic and cause conditions such as asthma, MANGE and scabies; others are vectors of disease organisms and are intermediate hosts for certain Cestodes.",MANGE,MITES
724993122,5/22/2015 18:25:11,1641492003,5/22/2015 18:24:56,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],is effective in preventing,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:25:40,1641492575,5/22/2015 18:25:18,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[PREVENTS],[PREVENTS],HEPATITIS A VACCINE preventing HAV INFECTION,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:29:07,1641496412,5/22/2015 18:28:25,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",A is within of,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:34:59,1641502834,5/22/2015 18:34:48,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[PREVENTS],[PREVENTS],preventing,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:35:52,1641503524,5/22/2015 18:35:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],preventing,none,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:47:09,1641515582,5/22/2015 18:46:40,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",A is within of,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:50:52,1641519195,5/22/2015 18:50:22,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],HEPATITIS A VACCINE is effective in preventing HAV INFECTION,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:51:50,1641520063,5/22/2015 18:50:53,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],is effective in preventing,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 18:56:44,1641525121,5/22/2015 18:56:20,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",HEPATITIS A VACCINE effective preventing HAV INFECTION,na,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 19:00:12,1641528570,5/22/2015 18:59:37,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],is preventing,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 19:02:33,1641531333,5/22/2015 19:02:20,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[SYMPTOM]
[NONE]",no,no,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 19:13:54,1641545013,5/22/2015 19:13:18,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],preventing,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 19:34:11,1641580708,5/22/2015 19:33:53,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],effective in preventing,n/a,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 19:44:03,1641592767,5/22/2015 19:43:46,false,bitcoinget,1.0,31947120,USA,CA,El Monte,198.101.125.188,[PREVENTS],[PREVENTS],preventing,N/A,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993122,5/22/2015 19:47:00,1641596192,5/22/2015 19:46:46,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[PREVENTS],[PREVENTS],effective in preventing,n/a,49,2,-1,61,21,TWrex-cause,804850-FS1,• HEPATITIS A VACCINE is effective in preventing HAV INFECTION among persons over age 1 and under age 40 if administered within 2 weeks of exposure to HAV.,HAV INFECTION,HEPATITIS A VACCINE
724993123,5/22/2015 16:51:24,1641420381,5/22/2015 16:50:55,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 16:57:23,1641424687,5/22/2015 16:56:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],using,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 16:59:09,1641425908,5/22/2015 16:58:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],should receive routine,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:05:52,1641429853,5/22/2015 17:05:41,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:08:00,1641431325,5/22/2015 17:07:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],VENOUS THROMBOEMBOLISM,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:08:45,1641431844,5/22/2015 17:08:17,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],is a a,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:09:32,1641432482,5/22/2015 17:08:15,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",n/a,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:10:04,1641432885,5/22/2015 17:08:42,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],receive routine,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:14:19,1641435756,5/22/2015 17:13:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],using,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:16:29,1641437273,5/22/2015 17:16:13,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],using,n/a,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:17:27,1641437854,5/22/2015 17:17:17,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:20:32,1641439960,5/22/2015 17:20:05,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],open prostatectomy patient should routine prophylaxis for VENOUS THROMBOEMBOLISM,n/a,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:20:39,1641440042,5/22/2015 17:20:27,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:20:48,1641440164,5/22/2015 17:20:16,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",an is THROMBOEMBOLISM or a,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993123,5/22/2015 17:21:29,1641440617,5/22/2015 17:20:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN,N/A,87,116,-1,108,160,TWrex-cause,803840-FS1,"If an open prostatectomy is needed, the patient should receive routine prophylaxis for VENOUS THROMBOEMBOLISM using LOW DOSE UNFRACTIONATED HEPARIN two or three times a day for a few days postsurgery.",VENOUS THROMBOEMBOLISM,LOW DOSE UNFRACTIONATED HEPARIN
724993124,5/22/2015 17:57:04,1641463185,5/22/2015 17:56:51,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],"cause,",N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:02:18,1641468378,5/22/2015 18:02:02,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[PART_OF],[PART_OF],of,N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:19:22,1641485730,5/22/2015 18:18:53,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]","cause, of",N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:19:51,1641486193,5/22/2015 18:19:32,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],"cause, of",N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:21:03,1641487470,5/22/2015 18:20:45,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SEIZURE and SE,na,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:21:04,1641487473,5/22/2015 18:20:34,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SEIZURE and SE,N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:25:31,1641492401,5/22/2015 18:24:54,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],Do,none,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:30:14,1641497664,5/22/2015 18:29:48,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[CAUSES],[CAUSES],"cause,",N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:36:43,1641504457,5/22/2015 18:36:17,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:39:02,1641507164,5/22/2015 18:38:31,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],"cause, and duration of SE",N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:40:48,1641509282,5/22/2015 18:40:28,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]","cause, of",N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:41:53,1641510464,5/22/2015 18:39:40,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[MANIFESTATION],[MANIFESTATION],duration,no,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:43:43,1641512524,5/22/2015 18:42:57,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],SEIZURE duration of SE,N/A,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:44:56,1641513460,5/22/2015 18:43:17,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],"cause, of SE",n/a,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993124,5/22/2015 18:46:02,1641514539,5/22/2015 18:45:43,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]","SEIZURE type, cause, duration SE affect mortality.",na,3,3,1,9,5,TWrex-cause,813520-FS1,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE
724993125,5/22/2015 16:45:04,1641415709,5/22/2015 16:44:49,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],found,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 16:51:54,1641420907,5/22/2015 16:51:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],are found in,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 16:54:28,1641422603,5/22/2015 16:53:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",are found in,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 16:55:30,1641423353,5/22/2015 16:54:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH] [SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]
[ASSOCIATED_WITH]","FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",n/a,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 16:56:32,1641424010,5/22/2015 16:55:20,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],found in,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 16:57:36,1641424835,5/22/2015 16:57:15,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is by,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 16:59:19,1641426022,5/22/2015 16:58:35,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],FEVER,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 16:59:23,1641426084,5/22/2015 16:59:12,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[IS_A],[IS_A],characterized,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 17:09:24,1641432380,5/22/2015 17:09:07,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],are found in,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 17:12:42,1641434654,5/22/2015 17:12:28,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],impairment,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 17:12:41,1641434656,5/22/2015 17:12:28,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,n/a,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 17:13:26,1641435139,5/22/2015 17:13:01,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is by,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 17:13:29,1641435205,5/22/2015 17:12:55,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",FEVER found in TTP,n/a,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 17:13:35,1641435286,5/22/2015 17:12:43,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","FEVER and neurologic impairment found in TTP characterized by thrombocytopenia, microangiopathic hemolytic anemia, renal failure.",n/a,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993125,5/22/2015 17:14:13,1641435723,5/22/2015 17:13:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],found in,N/A,2,47,1,6,50,TWrex-cause,813289-FS1,"• FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP
724993126,5/22/2015 16:42:45,1641414025,5/22/2015 16:42:25,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:47:43,1641417610,5/22/2015 16:47:20,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:47:43,1641417611,5/22/2015 16:46:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by Trichophyton and requires a shorter duration of treatment which may increase compliance.,n/a,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:48:21,1641418068,5/22/2015 16:48:09,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:50:21,1641419734,5/22/2015 16:50:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:52:39,1641421262,5/22/2015 16:52:15,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],for treatment of,n/a,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:53:57,1641422175,5/22/2015 16:53:21,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",treatment of caused by of,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:55:17,1641423170,5/22/2015 16:55:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],TINEA CAPITIS,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:57:13,1641424585,5/22/2015 16:56:35,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,Bany,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 16:59:28,1641426141,5/22/2015 16:58:59,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],for treatment of,N/a,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 17:07:09,1641430846,5/22/2015 17:06:56,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],effective treatment,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 17:07:16,1641430911,5/22/2015 17:06:25,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],for treatment of TINEA CAPITIS,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 17:10:52,1641433437,5/22/2015 17:10:41,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 17:10:55,1641433479,5/22/2015 17:10:41,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],effective,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993126,5/22/2015 17:11:49,1641434017,5/22/2015 17:11:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,135,53,-1,147,69,TWrex-cause,803524-FS1,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE
724993127,5/22/2015 17:29:02,1641444736,5/22/2015 17:28:45,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 17:41:18,1641451943,5/22/2015 17:41:08,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 17:49:01,1641456748,5/22/2015 17:48:30,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[CAUSES],[CAUSES],caused,n/a,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 17:54:07,1641460565,5/22/2015 17:53:55,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 17:54:31,1641460955,5/22/2015 17:53:44,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[CAUSES],[CAUSES],YAWS caused by TREPONEMA PERTENUE.,n/a,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 17:56:42,1641462817,5/22/2015 17:56:26,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 17:59:55,1641466114,5/22/2015 17:59:21,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",treatment caused by,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:02:41,1641468795,5/22/2015 18:01:39,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS],[PREVENTS],caused by TREPONEMA PERTENUE.,n/a,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:12:08,1641478120,5/22/2015 18:11:40,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",of caused by,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:12:44,1641478845,5/22/2015 18:12:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],YAWS caused by TREPONEMA PERTENUE.,na,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:14:28,1641480804,5/22/2015 18:13:46,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:15:44,1641481785,5/22/2015 18:15:05,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[CAUSES],[CAUSES],YAWS caused by TREPONEMA PERTENUE.,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:16:24,1641482637,5/22/2015 18:15:38,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:25:23,1641492199,5/22/2015 18:24:47,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[CAUSES],[CAUSES],YAWS TREPONEMA PERTENUE.,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993127,5/22/2015 18:35:05,1641502970,5/22/2015 18:34:45,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by,N/A,45,61,1,48,79,TWrex-cause,810971-FS1,Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
724993128,5/22/2015 16:41:42,1641413171,5/22/2015 16:41:22,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],versus,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:44:51,1641415557,5/22/2015 16:43:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,n/a,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:45:39,1641416225,5/22/2015 16:44:52,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],trial.,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:46:20,1641416572,5/22/2015 16:45:32,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],multicentre randomised trial.,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:49:26,1641418957,5/22/2015 16:48:59,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],randomised trial.,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:49:36,1641419104,5/22/2015 16:48:22,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],inhaled biaspart,n/a,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:52:10,1641421045,5/22/2015 16:51:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],a,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:54:16,1641422440,5/22/2015 16:54:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],TYPE 2 DIABETES:,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:55:51,1641423586,5/22/2015 16:55:33,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],twice daily,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 16:56:19,1641423858,5/22/2015 16:54:28,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],BASAL INSULIN GLARGINE for TYPE 2 DIABETES: a trial.,N/a,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 17:02:39,1641428280,5/22/2015 17:00:57,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 17:06:17,1641430136,5/22/2015 17:05:50,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,doesn't seem like anything,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 17:09:14,1641432220,5/22/2015 17:08:57,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trial.,N/A,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 17:09:55,1641432710,5/22/2015 17:09:24,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],inhaled,n/a,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993128,5/22/2015 17:11:24,1641433743,5/22/2015 17:10:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for,N/N,105,42,-1,119,64,TWrex-cause,800895-FS1,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE
724993129,5/22/2015 17:42:49,1641453121,5/22/2015 17:42:37,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 17:52:31,1641459301,5/22/2015 17:52:10,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treatment,n/a,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 17:56:02,1641462304,5/22/2015 17:55:52,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 17:57:50,1641463941,5/22/2015 17:57:24,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],CEFTRIAXONE treatment of patients with severe NEUROLOGIC LYME DISEASE,n/a,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 17:59:44,1641465898,5/22/2015 17:59:21,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is treatment with,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:08:52,1641474535,5/22/2015 18:08:07,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",the most well studied antibiotic for treatment of patients with more severe,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:16:34,1641482788,5/22/2015 18:16:00,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is treatment of with,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:18:07,1641484443,5/22/2015 18:17:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CEFTRIAXONE for treatment of NEUROLOGIC LYME DISEASE,na,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:18:14,1641484571,5/22/2015 18:17:52,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for treatment of patients with more severe,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:19:18,1641485661,5/22/2015 18:18:53,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],CEFTRIAXONE treatment NEUROLOGIC LYME DISEASE,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:23:22,1641489795,5/22/2015 18:22:13,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:28:41,1641495967,5/22/2015 18:28:26,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],treatment,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:32:30,1641500029,5/22/2015 18:32:04,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:36:28,1641504249,5/22/2015 18:35:11,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is treatment of with,N/A,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993129,5/22/2015 18:38:19,1641506164,5/22/2015 18:36:42,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],treatment,did not select none,93,2,-1,115,13,TWrex-cause,800730-FS1,• CEFTRIAXONE is the most well studied antibiotic for treatment of patients with more severe NEUROLOGIC LYME DISEASE ( 13 ;  60 ;  61.,NEUROLOGIC LYME DISEASE,CEFTRIAXONE
724993130,5/22/2015 18:26:46,1641493836,5/22/2015 18:26:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],after treatment with,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 18:27:06,1641494149,5/22/2015 18:26:47,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],PEPTIC ESOPHAGITIS treatment OMEPRAZOLE,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 18:37:44,1641505672,5/22/2015 18:37:30,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],treatment,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 18:48:27,1641516691,5/22/2015 18:47:59,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Healing,none,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 18:49:09,1641517379,5/22/2015 18:48:24,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",of treatment with,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 18:53:04,1641521315,5/22/2015 18:52:25,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 18:57:04,1641525419,5/22/2015 18:56:19,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],after treatment with OMEPRAZOLE,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 18:58:08,1641526471,5/22/2015 18:57:49,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",Healing relapse severe PEPTIC ESOPHAGITIS treatment OMEPRAZOLE,na,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 19:03:16,1641532146,5/22/2015 19:03:05,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 19:04:48,1641533983,5/22/2015 19:04:07,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment with,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 19:14:28,1641545878,5/22/2015 19:14:21,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],treatment,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 19:35:57,1641582963,5/22/2015 19:35:27,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment with,n/a,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 19:45:48,1641594837,5/22/2015 19:45:34,false,bitcoinget,1.0,31947120,USA,CA,El Monte,198.101.125.188,[TREATS],[TREATS],treatment,N/A,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 19:48:23,1641597914,5/22/2015 19:48:01,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment with,n/a,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993130,5/22/2015 19:53:20,1641604758,5/22/2015 19:52:31,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,n/a,110,150,-1,127,160,TWrex-cause,800775-FS1,"1]  Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe PEPTIC ESOPHAGITIS after treatment with OMEPRAZOLE",PEPTIC ESOPHAGITIS,OMEPRAZOLE
724993131,5/22/2015 17:25:10,1641442623,5/22/2015 17:24:46,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:34:37,1641447613,5/22/2015 17:34:11,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:36:02,1641448671,5/22/2015 17:35:30,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"Birn<span id=""transmark""></span>krant DTHALIDOMIDE for APHTHOUS ULCERS",n/a,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:37:03,1641449562,5/22/2015 17:36:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:39:22,1641450710,5/22/2015 17:39:06,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:40:19,1641451301,5/22/2015 17:40:03,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],for,N/a,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:43:40,1641453741,5/22/2015 17:43:24,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],for,n/a,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:44:17,1641454036,5/22/2015 17:43:37,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],DTHALIDOMIDE for APHTHOUS ULCERS,n/a,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:44:32,1641454252,5/22/2015 17:43:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:51:51,1641458818,5/22/2015 17:51:39,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:52:58,1641459605,5/22/2015 17:52:41,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:53:54,1641460350,5/22/2015 17:53:16,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],for,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 17:58:48,1641465007,5/22/2015 17:58:15,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",APHTHOUS ULCERS in HIV,n/a,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 18:06:04,1641471762,5/22/2015 18:03:46,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS,na,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993131,5/22/2015 18:09:52,1641475568,5/22/2015 18:09:15,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],in,N/A,27,11,-1,41,22,TWrex-cause,804856-FS1,Birnkrant DTHALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE
724993132,5/22/2015 17:28:04,1641444261,5/22/2015 17:27:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatments,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 17:40:51,1641451634,5/22/2015 17:40:37,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatments,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 17:47:17,1641455680,5/22/2015 17:46:59,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treatments of choice,n/a,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 17:52:21,1641459169,5/22/2015 17:52:01,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],FAMCICLOVIR treatments of choice for ZOSTER,n/a,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 17:53:35,1641460045,5/22/2015 17:53:02,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatments,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 17:55:53,1641462150,5/22/2015 17:55:29,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",or treatments of,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 17:58:27,1641464530,5/22/2015 17:57:53,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],are treatments of choice for both,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:00:48,1641466897,5/22/2015 18:00:07,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],both and herpes simplex reactivation.,n/a,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:11:00,1641476778,5/22/2015 18:10:32,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",or of,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:11:46,1641477654,5/22/2015 18:11:12,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FAMCICLOVIR treatments for ZOSTER,na,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:13:00,1641479091,5/22/2015 18:12:36,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],are treatments of choice for,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:14:28,1641480805,5/22/2015 18:14:12,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatments,none,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:14:34,1641480865,5/22/2015 18:14:16,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],FAMCICLOVIR treatments of ZOSTER,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:17:59,1641484293,5/22/2015 18:17:24,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],FAMCICLOVIR ZOSTER,N/A,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993132,5/22/2015 18:27:09,1641494189,5/22/2015 18:26:35,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],are treatments of choice,n/a,59,13,-1,64,24,TWrex-cause,800973-FS1,Acyclovir or FAMCICLOVIR are treatments of choice for both ZOSTER and herpes simplex reactivation.,ZOSTER,FAMCICLOVIR
724993133,5/22/2015 17:17:41,1641437980,5/22/2015 17:17:26,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:21:53,1641440844,5/22/2015 17:21:37,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompany,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:23:43,1641441894,5/22/2015 17:23:13,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by of,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:23:49,1641441972,5/22/2015 17:22:48,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],HYPERTHERMIA accompany thyroid storm PHEOCHROMOCYTOMA CRISIS triggered cases by the calorigenic properties of thyroid hormones 11 and catecholamines.,n/a,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:24:51,1641442506,5/22/2015 17:23:36,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"HYPERTHERMIA may accompany PHEOCHROMOCYTOMA CRIS<span id=""transmark""></span>IS",n/a,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:25:01,1641442586,5/22/2015 17:23:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may accompany,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:25:29,1641442852,5/22/2015 17:24:32,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:27:31,1641443901,5/22/2015 17:26:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may accompany,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:34:38,1641447628,5/22/2015 17:34:14,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[MANIFESTATION],[MANIFESTATION],that may accompany,N/a,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:35:37,1641448401,5/22/2015 17:35:26,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompany,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:38:54,1641450403,5/22/2015 17:38:19,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],results,n/a,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:39:15,1641450638,5/22/2015 17:38:48,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[MANIFESTATION],[MANIFESTATION],HYPERTHERMIA that may accompany PHEOCHROMOCYTOMA,n/a,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:42:22,1641452746,5/22/2015 17:41:52,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may accompany,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:43:23,1641453519,5/22/2015 17:42:59,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],accompany,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993133,5/22/2015 17:48:53,1641456641,5/22/2015 17:47:21,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],accompany,N/A,4,54,1,15,77,TWrex-cause,814218-FS1,"The HYPERTHERMIA that may accompany thyroid storm and PHEOCHROMOCYTOMA CRISIS also results from increased heat production, triggered in these cases by the calorigenic properties of thyroid hormones  11   and catecholamines.",HYPERTHERMIA,PHEOCHROMOCYTOMA CRISIS
724993134,5/22/2015 18:53:31,1641521739,5/22/2015 18:52:45,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with with with a with a,N/A,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 18:56:46,1641525138,5/22/2015 18:56:11,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING,N/A,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 19:01:29,1641530239,5/22/2015 19:01:11,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]
[OTHER]",ENDOMETRIAL CANCER with POSTMENOPAUSAL BLEEDING,na,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 19:04:45,1641533898,5/22/2015 19:04:35,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 19:11:15,1641541747,5/22/2015 19:08:23,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis is suspected,N/A,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 19:37:54,1641585319,5/22/2015 19:37:38,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],is suspected in women with,n/a,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 19:51:57,1641602751,5/22/2015 19:49:52,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],suspected in,n.a,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 20:02:33,1641617955,5/22/2015 20:00:24,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],women,n/a,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 20:22:05,1641646526,5/22/2015 20:21:38,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",is suspected in women with,N/A,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 20:22:07,1641646591,5/22/2015 20:21:50,false,neodev,1.0,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 20:38:21,1641668771,5/22/2015 20:37:28,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[SYMPTOM],[SYMPTOM],suspected,N/A,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 20:56:41,1641689019,5/22/2015 20:54:11,false,clixsense,1.0,19294877,USA,MA,Boston,96.233.18.188,[SYMPTOM],[SYMPTOM],Diagnosis ENDOMETRIAL CANCER suspected in women with POSTMENOPAUSAL BLEEDING,n/a,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 21:05:05,1641696851,5/22/2015 21:04:31,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],suspected in,n/a,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 21:10:31,1641701521,5/22/2015 21:10:10,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],is,n/a,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993134,5/22/2015 21:30:48,1641721021,5/22/2015 21:30:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",suspected in women with,n/a,57,11,1,79,29,TWrex-cause,814219-FS1,"Diagnosis  ENDOMETRIAL CANCER is suspected in women with POSTMENOPAUSAL BLEEDING in premenopausal women with abnormal bleeding, in postmenopausal women with a routine Pap test showing endometrial cells, and in any women with a routine Pap test showing atypical endometrial cells.",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CANCER
724993135,5/22/2015 18:54:22,1641522716,5/22/2015 18:53:36,false,neodev,1,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",with a with a,N/A,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 18:57:16,1641525638,5/22/2015 18:56:47,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],CONFUSIONAL MIGRAINE presents with a HEADACHE,N/A,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 19:01:54,1641530710,5/22/2015 19:01:32,false,clixsense,1,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH] [SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[OTHER]",CONFUSIONAL MIGRAINE presents HEADACHE,na,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 19:05:00,1641534193,5/22/2015 19:04:48,false,neodev,1,32103286,USA,CA,San Jose,23.27.44.137,[TREATS] [PREVENTS] [NONE],"[TREATS]
[PREVENTS]
[NONE]",no,no,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 19:13:25,1641544385,5/22/2015 19:11:18,false,neodev,1,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",presents with associated with,N/A,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 19:38:08,1641585706,5/22/2015 19:37:55,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],presents with,n/a,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 19:52:44,1641603853,5/22/2015 19:52:04,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],presents with,n/a,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 20:02:50,1641618352,5/22/2015 20:02:34,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],presents,n/a,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 20:22:29,1641647085,5/22/2015 20:22:07,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",presents with a,N/A,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 20:22:29,1641647088,5/22/2015 20:22:11,false,neodev,1,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 20:39:00,1641669423,5/22/2015 20:38:23,false,instagc,1,19602039,USA,WA,Bellevue,50.135.214.140,[MANIFESTATION],[MANIFESTATION],presents,N/A,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 21:01:43,1641693716,5/22/2015 20:59:50,false,clixsense,1,19294877,USA,MA,Boston,96.233.18.188,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]","CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with confusional state can last from minutes to 2 days.",n/a,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 21:05:16,1641696995,5/22/2015 21:05:06,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],presents,n/a,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 21:10:53,1641701952,5/22/2015 21:10:32,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],with,n/a,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993135,5/22/2015 21:31:12,1641721419,5/22/2015 21:30:49,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION] [IS_A],"[MANIFESTATION]
[IS_A]",presents with,n/a,37,0,1,44,20,TWrex-cause,813802-FS1,"CONFUSIONAL MIGRAINE presents with a HEADACHE which can be minimal, associated with a confusional state that can last from 10 minutes to 2 days.",HEADACHE,CONFUSIONAL MIGRAINE
724993136,5/22/2015 18:24:54,1641491708,5/22/2015 18:24:22,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF],[PART_OF],including the causative agents of,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:25:16,1641492126,5/22/2015 18:24:32,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[IS_A],[IS_A],HUMAN VIRUSES including VIRAL HEPATITIS,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:28:20,1641495560,5/22/2015 18:27:36,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is a of of a of of,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:34:46,1641502567,5/22/2015 18:34:20,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[CAUSES],[CAUSES],causative agents,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:35:01,1641502914,5/22/2015 18:33:52,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causative,none,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:46:36,1641515134,5/22/2015 18:46:04,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is is a of of of,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:50:19,1641518621,5/22/2015 18:49:28,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:50:51,1641519167,5/22/2015 18:48:24,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[IS_A],[IS_A],including the causative agents of VIRAL HEPATITIS,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:52:27,1641520681,5/22/2015 18:51:15,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",HUMAN VIRUSES including causative agents VIRAL HEPATITIS,na,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 18:59:34,1641527974,5/22/2015 18:58:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],including causative,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 19:02:12,1641531002,5/22/2015 19:01:53,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[SYMPTOM] [CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 19:13:17,1641544222,5/22/2015 19:13:00,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],prepared,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 19:33:51,1641580342,5/22/2015 19:33:34,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],including,n/a,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 19:43:44,1641592339,5/22/2015 19:42:53,false,bitcoinget,1.0,31947120,USA,CA,El Monte,198.101.125.188,[IS_A],[IS_A],including the causative,N/A,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993136,5/22/2015 19:46:44,1641595879,5/22/2015 19:46:21,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[PART_OF],[PART_OF],including,n/a,157,109,1,171,122,TWrex-cause,810218-FS1,"66   Since albumin human is prepared from pooled human plasma, it is a potential vehicle for transmission of HUMAN VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,HUMAN VIRUSES
724993137,5/22/2015 18:54:53,1641523349,5/22/2015 18:54:26,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",of by with,N/A,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 18:58:00,1641526289,5/22/2015 18:57:17,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],ULTRAVIOLET RADIATION; possible SUNBURN,N/A,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 19:02:29,1641531272,5/22/2015 19:01:55,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]
[OTHER]",ULTRAVIOLET RADIATION; radiation dermatitis SUNBURN,na,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 19:05:15,1641534619,5/22/2015 19:05:04,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 19:15:06,1641546643,5/22/2015 19:13:27,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],be aggravated,N/A,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 19:38:28,1641586030,5/22/2015 19:38:10,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],aggravated by,n/a,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 19:53:08,1641604402,5/22/2015 19:52:46,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[MANIFESTATION],[MANIFESTATION],'recall',n/a,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 20:03:57,1641620062,5/22/2015 20:02:52,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 20:22:45,1641647428,5/22/2015 20:22:33,false,neodev,1.0,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 20:22:57,1641647796,5/22/2015 20:22:30,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,No clear relation.,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 20:40:21,1641670992,5/22/2015 20:39:01,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[NONE],[NONE],N/A,psoriasis is aggravated by UV radiation and sunburn but those two terms are not related to each other,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 21:04:12,1641696142,5/22/2015 21:01:44,false,clixsense,1.0,19294877,USA,MA,Boston,96.233.18.188,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Lesions of psoriasis may be aggravated by exposure to ULTRAVIOLET RADIATION; and SUNBURN with methotrexate use,n/a,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 21:06:07,1641697804,5/22/2015 21:05:18,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,"These two terms are unrelated to each other, although they are both related to Psoriasis.",147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 21:11:10,1641702214,5/22/2015 21:10:55,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],aggravated,n/a,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993137,5/22/2015 21:33:55,1641723738,5/22/2015 21:31:13,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],may be aggravated by,n/a,147,81,1,153,102,TWrex-cause,810779-FS1,"a ,   b ,   c  Lesions of psoriasis may be aggravated by concomitant exposure to ULTRAVIOLET RADIATION; possible 'recall' radiation dermatitis and SUNBURN with methotrexate use",SUNBURN,ULTRAVIOLET RADIATION
724993138,5/22/2015 18:26:27,1641493481,5/22/2015 18:25:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[LOCATION],[LOCATION],over the,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 18:26:46,1641493851,5/22/2015 18:26:07,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[SYMPTOM],[SYMPTOM],sound over the STOMACH suggests GASTRIC OUTLET OBSTRUCTION,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 18:37:28,1641505425,5/22/2015 18:36:26,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[LOCATION],[LOCATION],STOMACH,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 18:47:58,1641516237,5/22/2015 18:47:22,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],suggests,none,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 18:48:21,1641516583,5/22/2015 18:47:38,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]",a a is caused by,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 18:52:24,1641520611,5/22/2015 18:51:43,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],splashing sound over the STOMACH suggests GASTRIC OUTLET OBSTRUCTION,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 18:56:17,1641524642,5/22/2015 18:54:15,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],when the body is shaken (succussion) suggests GASTRIC OUTLET,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 18:57:47,1641526117,5/22/2015 18:57:12,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",STOMACH body shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION,na,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 19:03:01,1641531864,5/22/2015 19:02:51,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 19:03:58,1641533045,5/22/2015 19:02:40,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[LOCATION],[LOCATION],suggests,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 19:14:20,1641545659,5/22/2015 19:14:08,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],suggests,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 19:35:24,1641582325,5/22/2015 19:34:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[LOCATION],[LOCATION],STOMACH,n/a,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 19:45:33,1641594479,5/22/2015 19:44:48,false,bitcoinget,1.0,31947120,USA,CA,El Monte,198.101.125.188,[LOCATION],[LOCATION],STOMACH,N/A,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 19:47:59,1641597399,5/22/2015 19:47:32,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[MANIFESTATION],[MANIFESTATION],suggests,n/a,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993138,5/22/2015 19:52:29,1641603474,5/22/2015 19:51:48,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],body shaken,n/a,79,133,-1,85,159,TWrex-cause,802914-FS1,"In a patient who has not eaten in the past 6 hours, a splashing sound over the STOMACH when the body is shaken (succussion) suggests GASTRIC OUTLET OBSTRUCTION or delayed gastric emptying caused by ileus.",STOMACH,GASTRIC OUTLET OBSTRUCTION
724993139,5/22/2015 16:43:43,1641414704,5/22/2015 16:43:24,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:49:56,1641419405,5/22/2015 16:48:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],to help not effective,"helps one, not the other - treat and none both apply, so best case is other",38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:50:25,1641419802,5/22/2015 16:49:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CONTRAINDICATES] [TREATS],"[TREATS]
[CONTRAINDICATES]",not effective,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:50:50,1641420123,5/22/2015 16:49:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected,n/a,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:52:40,1641421266,5/22/2015 16:52:18,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Case reports suggest,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:54:51,1641422904,5/22/2015 16:54:21,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],using,n/a,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:55:28,1641423300,5/22/2015 16:55:03,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],is is is,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:57:22,1641424681,5/22/2015 16:56:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],GANCICLOVIR,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 16:58:28,1641425497,5/22/2015 16:58:15,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 17:01:25,1641427537,5/22/2015 17:01:10,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],using,N/a,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 17:08:11,1641431443,5/22/2015 17:07:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],THERAPY,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 17:10:25,1641433067,5/22/2015 17:09:19,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CMV DRUG THERAPY using GANCICLOVIR,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 17:11:34,1641433858,5/22/2015 17:11:23,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treating,n/a,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 17:11:47,1641433980,5/22/2015 17:11:35,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],using,N/A,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993139,5/22/2015 17:12:12,1641434288,5/22/2015 17:11:38,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother not effective in treating fetus,n/a,38,61,-1,53,72,TWrex-cause,804818-FS1,Evidence: • Case reports suggest that CMV DRUG THERAPY using GANCICLOVIR is only proven to help the mother and is not effective in treating a fetus that is already infected ( 67.,CMV DRUG THERAPY,GANCICLOVIR
724993140,5/22/2015 16:51:49,1641420854,5/22/2015 16:51:34,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 16:58:13,1641425293,5/22/2015 16:57:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],investigational and,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 16:59:35,1641426204,5/22/2015 16:59:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],and,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:06:07,1641429949,5/22/2015 17:05:54,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],drug therapy,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:08:29,1641431674,5/22/2015 17:08:02,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPEREOSINOPHILIC SYNDROME,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:09:27,1641432406,5/22/2015 17:08:48,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]","A, A of therapy with",N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:10:35,1641433180,5/22/2015 17:09:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA,n/a,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:11:39,1641433907,5/22/2015 17:10:06,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[OTHER],[OTHER],therapy,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:14:34,1641435893,5/22/2015 17:14:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],drug therapy,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:16:43,1641437443,5/22/2015 17:16:30,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:17:39,1641437967,5/22/2015 17:17:29,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],therapy,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:20:51,1641440246,5/22/2015 17:20:43,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],drug therapy,N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:20:56,1641440316,5/22/2015 17:20:33,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],conventional and investigational drug therapy patients HYPEREOSINOPHILIC SYNDROME CLONAL EOSINOPHILIA,n/a,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:21:15,1641440459,5/22/2015 17:20:36,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]","HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINO<span id=""transmark""></span>PHILIA",n/a,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993140,5/22/2015 17:21:27,1641440594,5/22/2015 17:20:58,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]","A, A of drug therapy with",N/A,164,133,1,182,159,TWrex-cause,814619-FS1,"Kalac M, Quintas Cardama A, Vrhovac R, et al: A critical appraisal of conventional and investigational drug therapy in patients with HYPEREOSINOPHILIC SYNDROME and CLONAL EOSINOPHILIA",CLONAL EOSINOPHILIA,HYPEREOSINOPHILIC SYNDROME
724993141,5/22/2015 18:25:44,1641492678,5/22/2015 18:25:14,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH] [PART_OF] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",in autosomal dominant,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:26:05,1641493041,5/22/2015 18:25:41,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[SYMPTOM],[SYMPTOM],INTRACRANIAL ANEURYSMS in POLYCYSTIC KIDNEY DISEASE,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:29:59,1641497369,5/22/2015 18:29:12,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of by,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:36:09,1641503848,5/22/2015 18:35:00,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[MANIFESTATION],[MANIFESTATION],INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:36:57,1641504694,5/22/2015 18:36:19,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],in,none,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:47:34,1641515911,5/22/2015 18:47:12,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of by,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:51:42,1641519923,5/22/2015 18:50:54,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],INTRACRANIAL ANEURYSMS dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:54:14,1641522484,5/22/2015 18:51:51,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],in autosomal dominant POLYCYSTIC KIDNEY DISEASE,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 18:57:10,1641525504,5/22/2015 18:56:46,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",INTRACRANIAL ANEURYSMS autosomal dominant POLYCYSTIC KIDNEY DISEASE,na,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 19:02:37,1641531406,5/22/2015 19:00:14,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],in,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 19:02:48,1641531609,5/22/2015 19:02:37,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 19:14:06,1641545338,5/22/2015 19:13:55,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Follow up,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 19:34:53,1641581847,5/22/2015 19:34:15,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],in,n/a,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 19:44:47,1641593543,5/22/2015 19:44:04,false,bitcoinget,1.0,31947120,USA,CA,El Monte,198.101.125.188,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",in,N/A,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993141,5/22/2015 19:47:31,1641596813,5/22/2015 19:47:01,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[PART_OF],[PART_OF],in,n/a,13,58,1,34,83,TWrex-cause,814061-FS1,Follow up of INTRACRANIAL ANEURYSMS in autosomal dominant POLYCYSTIC KIDNEY DISEASE by magnetic resonance angiography.,INTRACRANIAL ANEURYSMS,POLYCYSTIC KIDNEY DISEASE
724993142,5/22/2015 17:30:56,1641445411,5/22/2015 17:29:45,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],both,N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 17:41:50,1641452305,5/22/2015 17:41:40,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],both,N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 17:49:42,1641457220,5/22/2015 17:49:17,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in,n/a,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 17:54:44,1641461110,5/22/2015 17:54:31,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],both,N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 17:55:19,1641461524,5/22/2015 17:55:04,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],"TERAZOSIN finasteride, in BENIGN PROSTATIC HYPERPLASIA",n/a,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 17:57:35,1641463630,5/22/2015 17:57:15,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of or,N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:01:45,1641467853,5/22/2015 18:00:47,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [CONTRAINDICATES],"[TREATS]
[CONTRAINDICATES]","efficacy of finasteride,",N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:03:26,1641469518,5/22/2015 18:03:05,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BENIGN PROSTATIC HYPERPLASIA,n/a,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:13:16,1641479270,5/22/2015 18:12:51,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of or,N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:14:41,1641480980,5/22/2015 18:14:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],efficacy of TERAZOSIN in BENIGN PROSTATIC HYPERPLASIA,na,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:16:41,1641482948,5/22/2015 18:16:23,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],The efficacy of,N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:17:28,1641483801,5/22/2015 18:16:34,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[NONE],[NONE],N/A,There's not enough information to tell.,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:18:19,1641484602,5/22/2015 18:17:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],efficacy,none,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:26:48,1641493916,5/22/2015 18:25:47,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[OTHER],[OTHER],TERAZOSIN BENIGN PROSTATIC HYPERPLASIA,N/A,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993142,5/22/2015 18:29:23,1641496712,5/22/2015 18:28:15,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[MANIFESTATION],[MANIFESTATION],efficacy of in,n/a,50,16,-1,77,25,TWrex-cause,804740-FS1,"The efficacy of TERAZOSIN finasteride, or both in BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
724993143,5/22/2015 16:41:02,1641412648,5/22/2015 16:40:50,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:42:32,1641413861,5/22/2015 16:41:57,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,n/a,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:44:28,1641415289,5/22/2015 16:44:13,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:44:42,1641415459,5/22/2015 16:44:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",clinical trial treatment of,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:47:28,1641417438,5/22/2015 16:46:18,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],in the treatment of,n/a,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:48:26,1641418159,5/22/2015 16:48:09,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:50:48,1641420115,5/22/2015 16:50:18,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",of treatment,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:53:27,1641421836,5/22/2015 16:53:06,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],OSTEOARTHRITIS,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:53:57,1641422200,5/22/2015 16:52:50,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],treatment of,N/a,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:55:15,1641423140,5/22/2015 16:54:59,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 16:59:03,1641425844,5/22/2015 16:58:24,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],the treatment,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 17:05:25,1641429713,5/22/2015 17:05:08,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 17:08:12,1641431451,5/22/2015 17:08:03,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 17:08:39,1641431767,5/22/2015 17:08:09,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993143,5/22/2015 17:09:23,1641432375,5/22/2015 17:08:58,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,114,84,-1,127,93,TWrex-cause,804025-FS1,1]  Muller Fassbender H. Double blind clinical trial of S adenosylmethionine versus IBUPROFEN in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,IBUPROFEN
724993144,5/22/2015 17:31:38,1641445807,5/22/2015 17:31:09,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 17:42:04,1641452525,5/22/2015 17:41:52,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 17:50:36,1641457630,5/22/2015 17:49:44,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],therapy,n/a,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 17:55:12,1641461477,5/22/2015 17:54:47,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 17:55:53,1641462151,5/22/2015 17:55:24,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],vsAMPHOTERICIN B therapy for INVASIVE ASPERGILLOSIS,n/a,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 17:57:54,1641464001,5/22/2015 17:57:39,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS],[TREATS],therapy,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:02:29,1641468563,5/22/2015 18:01:51,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],as therapy for,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:04:12,1641470285,5/22/2015 18:03:39,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],vsAMPHOTERICIN B as therapy for INVASIVE,n/s,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:13:45,1641479926,5/22/2015 18:13:19,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS],[TREATS],therapy,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:16:30,1641482698,5/22/2015 18:14:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS,na,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:17:01,1641483297,5/22/2015 18:16:44,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as therapy for,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:17:47,1641484113,5/22/2015 18:17:29,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:19:17,1641485653,5/22/2015 18:18:20,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:27:34,1641494646,5/22/2015 18:26:49,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],therapy,N/A,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993144,5/22/2015 18:29:47,1641497156,5/22/2015 18:29:24,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],as therapy for INVASIVE,n/a,106,76,-1,127,90,TWrex-cause,800220-FS1,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B
724993145,5/22/2015 16:50:51,1641420122,5/22/2015 16:50:12,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],Contains,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 16:56:57,1641424402,5/22/2015 16:55:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],ALLERGY to,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 16:58:42,1641425670,5/22/2015 16:58:00,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SIDE_EFFECT] [CONTRAINDICATES],"[CONTRAINDICATES]
[SIDE_EFFECT]",Anti infectives,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:05:39,1641429787,5/22/2015 17:05:27,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[PART_OF],[PART_OF],Contains,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:07:13,1641430874,5/22/2015 17:06:28,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],NEOMYCIN,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:08:13,1641431476,5/22/2015 17:07:40,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:08:14,1641431481,5/22/2015 17:07:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",ALLERGY to Neomycin or Other Anti infectives DTaP IPV/Hib (Pentacel ® Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,n/a,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:08:41,1641431781,5/22/2015 17:06:41,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SIDE_EFFECT],[SIDE_EFFECT],ALLERGY,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:13:54,1641435499,5/22/2015 17:13:28,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],Contains amounts,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:16:11,1641437036,5/22/2015 17:15:56,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],Contains,n/a,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:17:11,1641437724,5/22/2015 17:17:01,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CONTRAINDICATES],[CONTRAINDICATES],Contains,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:20:05,1641439605,5/22/2015 17:19:16,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],77 ALLERGY Neomycin Other Anti infectives DTaP IPV/Hib (Pentacel Contains trace amounts of NEOMYCIN sulfate,n/a,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:20:25,1641439833,5/22/2015 17:20:07,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SIDE_EFFECT],[SIDE_EFFECT],Contains,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:20:34,1641439984,5/22/2015 17:19:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SIDE_EFFECT] [OTHER],"[SIDE_EFFECT]
[OTHER]","ALLERGY to NEO<span id=""transmark""></span>MYCIN",n/a,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993145,5/22/2015 17:21:35,1641440671,5/22/2015 17:19:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],(Pentacel,N/A,4,104,1,10,112,TWrex-cause,811156-FS1,77  ALLERGY to Neomycin or Other Anti infectives  DTaP IPV/Hib (Pentacel ® ): Contains trace amounts of NEOMYCIN sulfate (≤4 pg) and polymyxin B (≤4 pg.,ALLERGY,NEOMYCIN
724993146,5/22/2015 16:47:16,1641417325,5/22/2015 16:47:04,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Drugs,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 16:53:23,1641421757,5/22/2015 16:53:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],to treat,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 16:55:54,1641423592,5/22/2015 16:55:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treat,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 16:58:57,1641425795,5/22/2015 16:58:17,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,n/a,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 16:59:35,1641426206,5/22/2015 16:59:13,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Drugs treat,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:00:07,1641426563,5/22/2015 16:59:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treat,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:00:50,1641427063,5/22/2015 17:00:15,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],treat,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:01:34,1641427623,5/22/2015 17:01:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],OCD,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:11:08,1641433635,5/22/2015 17:10:13,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],TREATMENT:,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:13:40,1641435310,5/22/2015 17:13:28,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treat,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:14:08,1641435685,5/22/2015 17:13:58,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treat,n/a,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:15:41,1641436675,5/22/2015 17:15:12,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],TREATMENT: Drugs such clomipramine FLUOXETINE treat OCD,n/a,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:16:10,1641437028,5/22/2015 17:15:23,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],TREATMENT: Drugs such as clomipramine and FLUOXETINE,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:16:13,1641437057,5/22/2015 17:15:33,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"FLUOXETINE to treat OC<span id=""transmark""></span>D",n/a,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993146,5/22/2015 17:17:02,1641437659,5/22/2015 17:15:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],to treat,N/A,77,42,-1,79,52,TWrex-cause,800027-FS1,TREATMENT: Drugs such as clomipramine and FLUOXETINE have been used to treat OCD,OCD,FLUOXETINE
724993147,5/22/2015 16:46:42,1641416940,5/22/2015 16:46:31,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],"disease,",N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 16:52:42,1641421303,5/22/2015 16:52:16,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",defined by manifestations:,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 16:55:25,1641423245,5/22/2015 16:54:59,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[MANIFESTATION],[MANIFESTATION],common clinical manifestations:,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 16:57:23,1641424688,5/22/2015 16:56:37,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]","PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",n/a,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 16:58:43,1641425692,5/22/2015 16:58:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is a by,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 16:59:21,1641426065,5/22/2015 16:58:59,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],manifestations:,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 16:59:53,1641426400,5/22/2015 16:59:38,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],manifestations:,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:00:35,1641426776,5/22/2015 17:00:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PROTEINURIA,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:09:55,1641432714,5/22/2015 17:09:40,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],manifestations:,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:13:11,1641434939,5/22/2015 17:12:57,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],"disease,",N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:13:35,1641435292,5/22/2015 17:13:10,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most common clinical manifestations:,n/a,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:14:43,1641436003,5/22/2015 17:14:11,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined its most common clinical manifestations: hypertension PROTEINURIA",n/a,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:14:53,1641436130,5/22/2015 17:13:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[MANIFESTATION],[MANIFESTATION],manifestations:,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:14:53,1641436134,5/22/2015 17:14:13,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[MANIFESTATION],[MANIFESTATION],"PREECLAMPSIA manifestations: PRO<span id=""transmark""></span>TEINURIA",n/a,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993147,5/22/2015 17:15:29,1641436527,5/22/2015 17:14:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],manifestations:,N/A,137,0,1,147,12,TWrex-cause,814426-FS1,"PREECLAMPSIA is not primarily a hypertensive disease, despite being defined by its most common clinical manifestations: hypertension and PROTEINURIA",PROTEINURIA,PREECLAMPSIA
724993148,5/22/2015 17:31:56,1641445996,5/22/2015 17:31:44,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[OTHER],[OTHER],or,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 17:42:19,1641452701,5/22/2015 17:42:06,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[OTHER],[OTHER],resistant,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 17:51:40,1641458651,5/22/2015 17:51:01,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],recommended,n/a,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 17:55:30,1641461668,5/22/2015 17:55:15,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[OTHER],[OTHER],or,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 17:57:07,1641463284,5/22/2015 17:55:54,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[PREVENTS],[PREVENTS],"SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B",nn/a,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 17:58:38,1641464785,5/22/2015 17:57:58,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",or is or is (with or without is,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:04:44,1641470905,5/22/2015 18:04:27,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS],[PREVENTS],"flucytosine alone is recommended for pyelonephritis,",n/a,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:06:59,1641472679,5/22/2015 18:06:17,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",is recommended for,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:14:31,1641480814,5/22/2015 18:13:48,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",or is (with or without or is is,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:17:03,1641483334,5/22/2015 18:16:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],"IV AMPHOTERICIN B recommended for SYMPTOMATIC CYSTITIS,",na,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:17:20,1641483665,5/22/2015 18:17:03,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],is recommended for,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:18:27,1641484749,5/22/2015 18:17:49,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],"IV AMPHOTERICIN B recommended for SYMPTOMATIC CYSTITIS,",N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:20:28,1641486865,5/22/2015 18:19:18,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],recommended,none,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:27:57,1641495113,5/22/2015 18:27:35,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],recommended for,N/A,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993148,5/22/2015 18:30:50,1641498195,5/22/2015 18:29:48,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],"is recommended for SYMPTOMATIC CYSTITIS,",n/a,147,90,-1,184,107,TWrex-cause,803416-FS1,"425   When fluconazole resistant  Candida  (e.g.,  C. glabrata ,  C. krusei ) are likely, IV AMPHOTERICIN B or oral flucytosine is recommended for SYMPTOMATIC CYSTITIS, IV AMPHOTERICIN B (with or without flucytosine) or oral flucytosine alone is recommended for pyelonephritis, and IV amphotericin B (with or without flucytosine) is recommended for fungus balls.",SYMPTOMATIC CYSTITIS,IV AMPHOTERICIN B
724993149,5/22/2015 18:24:20,1641491021,5/22/2015 18:23:44,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],always requires delivery after,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:24:31,1641491250,5/22/2015 18:24:13,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],ECLAMPSIA after SEIZURES,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:27:17,1641494387,5/22/2015 18:26:34,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],after,CFsurvey88,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:33:50,1641501602,5/22/2015 18:33:11,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],requires delivery,none,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:34:19,1641502124,5/22/2015 18:33:45,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[SYMPTOM],[SYMPTOM],always requires delivery after,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:46:00,1641514523,5/22/2015 18:45:30,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],and,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:48:23,1641516625,5/22/2015 18:46:41,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],requires delivery after SEIZURES,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:49:23,1641517612,5/22/2015 18:48:47,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ECLAMPSIA after SEIZURES,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:51:15,1641519515,5/22/2015 18:49:51,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",ECLAMPSIA requires delivery after SEIZURES,na,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:55:31,1641523845,5/22/2015 18:53:50,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[CONTRAINDICATES],[CONTRAINDICATES],severe hypertension have been controlled.,none,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:58:41,1641527012,5/22/2015 18:57:13,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",requires,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 18:58:46,1641527115,5/22/2015 18:56:37,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CONTRAINDICATES],[CONTRAINDICATES],always requires delivery after SEIZURES,n/a,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 19:01:49,1641530603,5/22/2015 19:01:39,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[LOCATION] [CAUSES] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 19:13:00,1641543971,5/22/2015 19:12:47,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],severe hypertension,N/A,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993149,5/22/2015 19:33:33,1641580135,5/22/2015 19:33:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],after,n/a,41,0,1,48,9,TWrex-cause,814109-FS1,ECLAMPSIA always requires delivery after SEIZURES and severe hypertension have been controlled.,SEIZURES,ECLAMPSIA
724993150,5/22/2015 17:22:55,1641441412,5/22/2015 17:22:41,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],"chemotherapy,",N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:26:54,1641443610,5/22/2015 17:26:18,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of,N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:27:03,1641443721,5/22/2015 17:26:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA early mortality.,n/a,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:28:20,1641444329,5/22/2015 17:27:31,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS] [OTHER],"[TREATS]
[OTHER]","(G CSF reduce FEBRILE NEUT<span id=""transmark""></span>ROPENIA",n/a,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:28:25,1641444386,5/22/2015 17:27:31,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],reduce,N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:35:03,1641447945,5/22/2015 17:33:53,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],prophylactic reduce,N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:36:27,1641449070,5/22/2015 17:35:45,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],does primary prophylactic use of granulocyte colony stimulating factor reduce FEBRILE NEUTROPENIA,N/a,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:36:42,1641449298,5/22/2015 17:36:29,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],reduce,N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:40:57,1641451693,5/22/2015 17:40:31,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],(G CSF reduce FEBRILE NEUTROPENIA,n/a,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:41:15,1641451930,5/22/2015 17:40:48,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],reduce,n/a,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:45:29,1641454731,5/22/2015 17:44:35,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",reduce,N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:49:04,1641456781,5/22/2015 17:48:44,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of,N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:49:34,1641457077,5/22/2015 17:49:22,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CONTRAINDICATES],[CONTRAINDICATES],stimulating,N/A,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:55:57,1641462210,5/22/2015 17:53:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],(G CSF reduce FEBRILE NEUTROPENIA,na,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993150,5/22/2015 17:57:00,1641463120,5/22/2015 17:54:17,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",reduce FEBRILE NEUTROPENIA and early mortality.,n/a,178,165,-1,196,170,TWrex-cause,803814-FS1,"PubMed ID: 17634496  QUESTION  In adult patients with cancer who are receiving chemotherapy, does primary prophylactic use of granulocyte colony stimulating factor (G CSF reduce FEBRILE NEUTROPENIA and early mortality.",FEBRILE NEUTROPENIA,G CSF
724993151,5/22/2015 16:43:58,1641414875,5/22/2015 16:43:46,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],given,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:50:18,1641419707,5/22/2015 16:49:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],given for,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:50:44,1641420053,5/22/2015 16:50:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],given for,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:52:09,1641421048,5/22/2015 16:50:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]","As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",n/a,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:53:00,1641421485,5/22/2015 16:52:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],can be given for,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:55:26,1641423281,5/22/2015 16:54:52,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],can be given for,n/a,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:56:01,1641423653,5/22/2015 16:55:31,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",is a cause of or is,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:57:54,1641425058,5/22/2015 16:57:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],hypomagnesia,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 16:58:41,1641425675,5/22/2015 16:58:29,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],cause of,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 17:02:19,1641427953,5/22/2015 17:01:32,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],can be given for,N/a,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 17:08:26,1641431643,5/22/2015 17:08:13,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 17:11:39,1641433911,5/22/2015 17:10:26,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],MAGNESIUM SULPHATE can be given for TORSADES,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 17:11:49,1641434013,5/22/2015 17:11:35,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],given,n/a,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 17:12:02,1641434150,5/22/2015 17:11:49,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],cause,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993151,5/22/2015 17:12:11,1641434283,5/22/2015 17:11:46,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or is,N/A,87,51,-1,94,69,TWrex-cause,804829-FS1,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE
724993152,5/22/2015 16:50:08,1641419527,5/22/2015 16:49:54,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],caused,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 16:55:55,1641423620,5/22/2015 16:55:36,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 16:57:59,1641425134,5/22/2015 16:57:41,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],to be caused by,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:05:25,1641429709,5/22/2015 17:05:14,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],caused,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:06:27,1641430221,5/22/2015 17:06:06,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HIV,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:06:40,1641430441,5/22/2015 17:06:19,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:07:11,1641430863,5/22/2015 17:06:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Although rare in the United States, RHINOSCLEROMA believed to be caused by KLEBSIELLA RHINOSCLEROMATIS can occur in immigrants from developing countries or in HIV infected persons.",n/a,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:07:37,1641431109,5/22/2015 17:06:50,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by or,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:13:27,1641435183,5/22/2015 17:13:11,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:15:54,1641436851,5/22/2015 17:15:43,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:16:58,1641437628,5/22/2015 17:16:46,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],caused,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:19:14,1641439033,5/22/2015 17:18:55,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],RHINOSCLEROMA believed to be caused by KLEBSIELLA RHINOSCLEROMATIS,n/a,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:19:36,1641439256,5/22/2015 17:19:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:20:13,1641439714,5/22/2015 17:19:44,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by or,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993152,5/22/2015 17:20:58,1641440350,5/22/2015 17:19:36,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,36,76,1,48,103,TWrex-cause,810509-FS1,"Although rare in the United States, RHINOSCLEROMA believed to be caused by  KLEBSIELLA RHINOSCLEROMATIS , can occur in immigrants from developing countries or in HIV infected persons.",RHINOSCLEROMA,KLEBSIELLA RHINOSCLEROMATIS
724993153,5/22/2015 17:26:37,1641443405,5/22/2015 17:25:22,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:35:01,1641447936,5/22/2015 17:34:40,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of OF,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:36:56,1641449519,5/22/2015 17:36:12,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"L DEPRENYL treatment of MILD DEMENTIA OF THE ALZHEIMER T<span id=""transmark""></span>YPE:",n/a,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:37:55,1641449886,5/22/2015 17:37:10,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:39:39,1641450945,5/22/2015 17:39:27,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:40:43,1641451552,5/22/2015 17:40:21,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],in the treatment of,N/a,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:43:54,1641453871,5/22/2015 17:43:41,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treatment,n/a,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:44:53,1641454450,5/22/2015 17:44:24,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE:,n/a,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:46:29,1641455211,5/22/2015 17:44:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:52:06,1641459010,5/22/2015 17:51:54,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:53:29,1641459979,5/22/2015 17:53:02,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of OF,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:54:37,1641461049,5/22/2015 17:54:03,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],in the treatment,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 17:59:01,1641465193,5/22/2015 17:58:49,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],treatment of MILD DEMENTIA,n/a,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 18:07:04,1641472760,5/22/2015 18:06:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],L DEPRENYL in treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE:,na,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993153,5/22/2015 18:07:23,1641473065,5/22/2015 18:06:46,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of OF of a,N/A,73,42,-1,107,52,TWrex-cause,804152-FS1,"Burke WJ, Roccaforte WH, Wengel SP et al: L DEPRENYL in the treatment of MILD DEMENTIA OF THE ALZHEIMER TYPE: results of a 15 month trial.",MILD DEMENTIA OF THE ALZHEIMER TYPE,L DEPRENYL
724993154,5/22/2015 17:24:37,1641442363,5/22/2015 17:24:19,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CONTRAINDICATES],[CONTRAINDICATES],produced,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:33:06,1641446586,5/22/2015 17:32:37,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],CHRONIC PAIN that was previously unresponsive to buprenorphine alone FENTANYL,n/a,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:34:08,1641447299,5/22/2015 17:33:46,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",a with,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:35:28,1641448243,5/22/2015 17:33:12,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[NONE],[NONE],n/a,not related (in this sentence),169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:36:17,1641448840,5/22/2015 17:35:13,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],previously unresponsive to,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:38:57,1641450438,5/22/2015 17:37:58,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],terminally,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:40:00,1641451074,5/22/2015 17:39:19,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[NONE],[NONE],N/a,Unrelated terms.,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:43:20,1641453487,5/22/2015 17:41:06,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],unresponsive to buprenorphine alone,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:43:22,1641453518,5/22/2015 17:42:59,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(during after,n/a,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:43:37,1641453699,5/22/2015 17:43:00,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[NONE],[NONE],n/a,not sure the relationship,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:51:32,1641458530,5/22/2015 17:51:18,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],patient,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:52:19,1641459163,5/22/2015 17:51:19,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [CONTRAINDICATES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[CONTRAINDICATES]",was unresponsive to buprenorphine alone,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:52:38,1641459353,5/22/2015 17:52:17,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",a with,N/A,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 17:58:06,1641464266,5/22/2015 17:57:54,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",previously unresponsive to buprenorphine alone,n/a,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993154,5/22/2015 18:03:34,1641469637,5/22/2015 18:02:25,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],produced satisfactory analgesia in patient with CHRONIC PAIN FENTANYL,na,169,249,-1,180,257,TWrex-cause,804352-FS1,"3 , 202 ]   Droperidol Concomitant administration has produced satisfactory analgesia (during and after surgery [ 60 ] and also in a terminally ill patient with severe, CHRONIC PAIN that was previously unresponsive to buprenorphine alone [ 37 ])    FENTANYL",CHRONIC PAIN,FENTANYL
724993155,5/22/2015 16:40:46,1641412480,5/22/2015 16:40:33,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],cases,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:41:56,1641413336,5/22/2015 16:41:23,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,n/a,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:44:09,1641415008,5/22/2015 16:42:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],REFLECT,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:44:12,1641415030,5/22/2015 16:42:54,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],REFLECT,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:46:10,1641416373,5/22/2015 16:44:27,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[NONE],[NONE],n/a,"your selection already covers 90 of all words, your selection is meaningless to me, and ripped apart",5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:48:08,1641417895,5/22/2015 16:47:31,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",cases,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:50:16,1641419647,5/22/2015 16:49:31,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],FROM,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:52:48,1641421344,5/22/2015 16:52:04,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[NONE],[NONE],N/a,Terms aren't related,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:53:04,1641421518,5/22/2015 16:52:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],HERPES ZOSTER,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:54:56,1641422959,5/22/2015 16:54:42,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SIDE_EFFECT],[SIDE_EFFECT],cases,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 16:58:22,1641425418,5/22/2015 16:57:25,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],cases REFLECT,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 17:04:46,1641429274,5/22/2015 17:04:19,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],REFLECT,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 17:08:02,1641431339,5/22/2015 17:07:44,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],REFLECT,n/a,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 17:08:07,1641431415,5/22/2015 17:07:37,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],cases,N/A,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993155,5/22/2015 17:10:56,1641433484,5/22/2015 17:08:02,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]","Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GAN<span id=""transmark""></span>GLIA.",n/a,5,25,1,17,62,TWrex-cause,815045-FS1,Most HERPES ZOSTER cases REFLECT VZV REACTIVATION FROM GANGLIA.,HERPES ZOSTER,REFLECT VZV REACTIVATION FROM GANGLIA
724993156,5/22/2015 16:43:20,1641414443,5/22/2015 16:43:06,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:48:41,1641418353,5/22/2015 16:48:23,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],therapy for,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:49:36,1641419096,5/22/2015 16:48:47,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",n/a,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:49:43,1641419185,5/22/2015 16:49:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:52:17,1641421084,5/22/2015 16:51:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],thrombolytic therapy,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:54:21,1641422498,5/22/2015 16:53:23,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],adjunctive treatment for,n/a,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:55:00,1641422983,5/22/2015 16:54:40,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [TREATS],"[TREATS]
[IS_A]",an treatment therapy,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:56:21,1641423867,5/22/2015 16:55:45,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],thrombolytic therapy,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 16:58:14,1641425306,5/22/2015 16:57:33,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 17:01:07,1641427362,5/22/2015 17:00:48,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],treatment for,N/a,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 17:07:55,1641431296,5/22/2015 17:07:40,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 17:09:17,1641432260,5/22/2015 17:08:31,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],adjunctive treatment,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 17:11:22,1641433740,5/22/2015 17:11:12,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 17:11:33,1641433844,5/22/2015 17:11:11,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993156,5/22/2015 17:12:30,1641434549,5/22/2015 17:11:25,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,83,17,-1,109,24,TWrex-cause,804156-FS1,"Prins MH, Hirsh JHEPARIN as an adjunctive treatment after thrombolytic therapy for ACUTE MYOCARDIAL INFARCTION",ACUTE MYOCARDIAL INFARCTION,HEPARIN
724993157,5/22/2015 17:56:49,1641462911,5/22/2015 17:56:36,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment caused,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:01:57,1641468077,5/22/2015 18:01:37,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Treatment of caused by,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:18:50,1641485155,5/22/2015 18:18:14,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Treatment of caused by,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:19:30,1641485844,5/22/2015 18:19:09,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:20:33,1641486935,5/22/2015 18:20:17,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[CAUSES],[CAUSES],OPHTHALMIA NEONATORUM caused by NGONORRHOEAE,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:20:44,1641487178,5/22/2015 18:19:11,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],OPHTHALMIA NEONATORUM caused by NGONORRHOEAE,na,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:24:53,1641491657,5/22/2015 18:24:27,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:29:47,1641497154,5/22/2015 18:29:34,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[CAUSES],[CAUSES],caused,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:36:01,1641503712,5/22/2015 18:33:40,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:38:30,1641506385,5/22/2015 18:38:12,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:39:40,1641507883,5/22/2015 18:38:20,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[CAUSES],[CAUSES],caused by,not chosen,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:40:25,1641508893,5/22/2015 18:39:56,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Treatment of caused by,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:42:56,1641511690,5/22/2015 18:42:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],OPHTHALMIA NEONATORUM caused by NGONORRHOEAE,N/A,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:43:15,1641512074,5/22/2015 18:43:00,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],caused by,n/a,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993157,5/22/2015 18:45:42,1641514212,5/22/2015 18:45:19,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],Treatment OPHTHALMIA NEONATORUM caused NGONORRHOEAE,na,26,67,1,46,78,TWrex-cause,810592-FS1,"167 ,   292  Treatment of OPHTHALMIA NEONATORUM   +    caused by  NGONORRHOEAE",OPHTHALMIA NEONATORUM,GONORRHOEAE
724993158,5/22/2015 16:49:37,1641419105,5/22/2015 16:48:54,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[OTHER],[OTHER],et,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 16:55:02,1641423005,5/22/2015 16:54:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment with,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 16:57:16,1641424602,5/22/2015 16:57:00,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],successful treatment,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:04:23,1641429009,5/22/2015 17:03:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [LOCATION],"[TREATS]
[LOCATION]",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG,n/a,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:04:37,1641429217,5/22/2015 17:03:23,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:04:54,1641429338,5/22/2015 17:04:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],DHPG,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:05:37,1641429778,5/22/2015 17:05:06,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",a with,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:05:40,1641429788,5/22/2015 17:05:20,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:12:36,1641434617,5/22/2015 17:12:18,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],successful treatment,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:15:12,1641436375,5/22/2015 17:14:59,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:16:32,1641437310,5/22/2015 17:16:09,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:18:21,1641438462,5/22/2015 17:18:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment with,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:18:49,1641438720,5/22/2015 17:18:26,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],treatment with DHPG,N/A,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:18:53,1641438771,5/22/2015 17:18:11,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],MYOCARDITIS renal transplant recipient: successful treatment with DHPG,n/a,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993158,5/22/2015 17:19:43,1641439344,5/22/2015 17:18:27,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipi<span id=""transmark""></span>ent: treatment with DHPG",n/a,37,146,-1,85,150,TWrex-cause,800352-FS1,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG
724993159,5/22/2015 18:52:00,1641520173,5/22/2015 18:51:06,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",cause with,N/A,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 18:55:27,1641523770,5/22/2015 18:54:45,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CAFÉ AU LAIT SPOTS has been linked with MCCUNE ALBRIGHT SYNDROME,N/A,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 19:00:31,1641529004,5/22/2015 18:59:53,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",CAFÉ AU LAIT SPOTS not cause linked with MCCUNE ALBRIGHT SYNDROME,na,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 19:04:14,1641533345,5/22/2015 19:04:02,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 19:07:28,1641537050,5/22/2015 19:06:39,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Associated with,N/A,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 19:37:16,1641584541,5/22/2015 19:36:59,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],linked with,n/a,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 19:49:36,1641599622,5/22/2015 19:49:19,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],cause,n/a,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 19:57:55,1641611152,5/22/2015 19:56:06,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],multiple spots,n/a,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 20:21:04,1641644850,5/22/2015 20:20:26,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,No direct relation.,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 20:21:29,1641645561,5/22/2015 20:21:18,false,neodev,1.0,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 20:37:00,1641667364,5/22/2015 20:36:27,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[ASSOCIATED_WITH],[ASSOCIATED_WITH],linked,N/A,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 20:52:31,1641684759,5/22/2015 20:49:32,false,clixsense,1.0,19294877,USA,MA,Boston,96.233.18.188,[CAUSES],[CAUSES],While CAFÉ AU LAIT SPOTS has been linked with neurofibromatosis and MCCUNE ALBRIGHT SYNDROME,n/a,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 21:04:13,1641696163,5/22/2015 21:03:49,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],linked with,n/a,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 21:09:54,1641700994,5/22/2015 21:09:22,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],and,n/a,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993159,5/22/2015 21:30:03,1641720289,5/22/2015 21:28:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],linked with,n/a,78,208,1,95,232,TWrex-cause,812651-FS1,"Associated conditions     Neurofibromatosis type I café au lait spot    While CAFÉ AU LAIT SPOTS do not cause any ailment themselves, having multiple spots has been linked with neurofibromatosis and the rare MCCUNE ALBRIGHT SYNDROME",CAFÉ AU LAIT SPOTS,MCCUNE ALBRIGHT SYNDROME
724993160,5/22/2015 18:21:15,1641487620,5/22/2015 18:20:42,false,neodev,1,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:21:16,1641487642,5/22/2015 18:20:53,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[SIDE_EFFECT],[SIDE_EFFECT],Intermediate risk for,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:22:31,1641489020,5/22/2015 18:22:14,false,instagc,1,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],STROKE: 325 mg daily WARFARIN,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:22:32,1641489042,5/22/2015 18:22:00,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],Intermediate risk for STROKE: WARFARIN,na,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:29:23,1641496733,5/22/2015 18:28:26,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],risk,none,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:32:01,1641499465,5/22/2015 18:31:30,false,prodege,1,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],WARFARIN,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:38:16,1641506163,5/22/2015 18:38:06,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:40:54,1641509366,5/22/2015 18:40:13,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],risk for STROKE: or WARFARIN,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:42:00,1641510680,5/22/2015 18:41:42,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:45:52,1641514366,5/22/2015 18:45:11,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],risk for STROKE: WARFARIN,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:47:26,1641515840,5/22/2015 18:44:54,false,clixsense,1,6375330,CAN,ON,Ottawa,209.195.106.138,[NONE],[NONE],or,The sentence seems disjointed and incomplete,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:47:27,1641515846,5/22/2015 18:47:00,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",Intermediate risk STROKE: mg daily WARFARIN,na,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:48:58,1641517093,5/22/2015 18:47:09,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],risk for STROKE: 325 mg daily,n/a,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 18:52:27,1641520689,5/22/2015 18:51:48,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",risk for,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993160,5/22/2015 19:11:34,1641542129,5/22/2015 19:11:12,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],Intermediate risk,N/A,51,75,-1,56,83,TWrex-cause,804512-FS1,"744 ,   773 ,   776 ,   826  Intermediate risk for STROKE: 325 mg daily or WARFARIN",STROKE,WARFARIN
724993161,5/22/2015 17:24:00,1641442070,5/22/2015 17:23:46,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],syndrome designated,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:30:39,1641445203,5/22/2015 17:29:32,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],HTLV 1 causes adult TROPICAL SPASTIC PARAPARESIS,n/a,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:33:10,1641446606,5/22/2015 17:31:51,false,clixsense,1,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"HTLV 1 causes TROPICAL SPASTIC PA<span id=""transmark""></span>RAPARESIS","ride like the wind, fight proud my son - you're the defender god has sent",139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:33:43,1641447057,5/22/2015 17:32:58,false,neodev,1,29579905,GBR,"","",5.152.206.71,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",causes or,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:35:09,1641447999,5/22/2015 17:34:12,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:37:51,1641449853,5/22/2015 17:37:30,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],neurodegenerative syndrome,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:38:52,1641450368,5/22/2015 17:38:01,false,instagc,1,24252915,GBR,K6,Southsea,80.44.194.25,[CAUSES],[CAUSES],causes,N/a,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:41:04,1641451772,5/22/2015 17:39:30,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:42:59,1641453260,5/22/2015 17:42:43,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[PART_OF],[PART_OF],TROPICAL SPASTIC PARAPARESIS or HTLV 1,n/a,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:42:58,1641453268,5/22/2015 17:42:33,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[CAUSES],[CAUSES],causes designated,n/a,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:51:07,1641458146,5/22/2015 17:50:52,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],syndrome,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:51:10,1641458162,5/22/2015 17:50:01,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[CAUSES],[CAUSES],causes adult,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:52:14,1641459101,5/22/2015 17:51:32,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",an or,N/A,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 17:57:53,1641463961,5/22/2015 17:57:42,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",and an unusual neurodegenerative syndrome,n/a,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993161,5/22/2015 18:02:22,1641468465,5/22/2015 18:00:17,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],designated TROPICAL SPASTIC PARAPARESIS or HTLV 1,na,139,0,1,166,6,TWrex-cause,811684-FS1,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1
724993162,5/22/2015 17:43:02,1641453324,5/22/2015 17:42:50,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 17:53:08,1641459754,5/22/2015 17:52:32,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],essential diagnostic features,n/a,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 17:56:16,1641462476,5/22/2015 17:56:05,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 17:58:20,1641464398,5/22/2015 17:57:52,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],THROMBOCYTOPENIA and microangiopathic hemolytic anemia are features of TTP,n/a,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:00:41,1641466771,5/22/2015 17:59:47,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",THROMBOCYTOPENIA of,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:09:40,1641475362,5/22/2015 18:08:56,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",are the essential diagnostic features of,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:17:31,1641483857,5/22/2015 18:16:40,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:18:37,1641484899,5/22/2015 18:18:11,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],THROMBOCYTOPENIA diagnostic features of TTP,na,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:18:37,1641484902,5/22/2015 18:18:16,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],are the essential diagnostic features of,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:19:41,1641485974,5/22/2015 18:19:19,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[SYMPTOM],[SYMPTOM],THROMBOCYTOPENIA features of TTP,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:23:57,1641490552,5/22/2015 18:23:23,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],features,none,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:28:59,1641496304,5/22/2015 18:28:42,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:32:57,1641500566,5/22/2015 18:32:33,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:37:17,1641505150,5/22/2015 18:36:48,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF],[PART_OF],of,N/A,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993162,5/22/2015 18:38:10,1641506006,5/22/2015 18:37:36,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],essential diagnostic features of TTP,n/a,13,109,1,28,112,TWrex-cause,813787-FS1,Rationale: • THROMBOCYTOPENIA and microangiopathic hemolytic anemia are the essential diagnostic features of TTP,THROMBOCYTOPENIA,TTP
724993163,5/22/2015 16:48:51,1641418494,5/22/2015 16:48:22,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 16:54:42,1641422791,5/22/2015 16:54:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 16:56:58,1641424401,5/22/2015 16:56:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:02:51,1641428399,5/22/2015 17:01:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","ANTIMALARIAL DRUG When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",n/a,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:03:05,1641428535,5/22/2015 17:02:50,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:04:15,1641428886,5/22/2015 17:03:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],malaria,N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:04:19,1641428956,5/22/2015 17:02:28,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PART_OF] [IS_A] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]","DRUG treated, a with treatment of on drugs of",N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:05:19,1641429668,5/22/2015 17:04:53,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],"treated,",N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:12:17,1641434368,5/22/2015 17:11:54,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],"treated,",N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:14:58,1641436176,5/22/2015 17:14:47,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:16:07,1641436996,5/22/2015 17:15:12,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],"treated,",N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:18:11,1641438334,5/22/2015 17:17:46,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"ANTIMALARIAL DRUG When properly treated, a patient with malaria can expect a complete recovery.[80]",n/a,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:18:14,1641438356,5/22/2015 17:17:11,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]","DRUG treated, a with treatment of of drugs of",N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:18:25,1641438495,5/22/2015 17:17:28,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"ANTIMALARIAL treatment of MAL<span id=""transmark""></span>ARIA",n/a,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993163,5/22/2015 17:18:28,1641438531,5/22/2015 17:17:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],"treated,",N/A,35,31,-1,41,48,TWrex-cause,803469-FS1,"Treatment Further information: ANTIMALARIAL DRUG  When properly treated, a patient with malaria can expect a complete recovery.[80] The treatment of MALARIA depends on the severity of the disease; whether patients who can take oral drugs have to be admitted depends on the assessment and the experience of the clinician.",MALARIA,ANTIMALARIAL DRUG
724993164,5/22/2015 18:23:23,1641489828,5/22/2015 18:22:54,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],it can be recommended for almost anyone with,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:23:54,1641490530,5/22/2015 18:23:16,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[SYMPTOM],[SYMPTOM],TRIGEMINAL NEURALGIA who is bothered by PAIN.,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:24:50,1641491603,5/22/2015 18:23:56,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [IS_A],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with is by treat,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:32:46,1641500293,5/22/2015 18:31:50,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],bothered by,none,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:33:25,1641501126,5/22/2015 18:32:50,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[SYMPTOM],[SYMPTOM],bothered,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:44:32,1641513043,5/22/2015 18:43:26,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",with is by treat,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:45:30,1641514057,5/22/2015 18:44:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],TRIGEMINAL NEURALGIA used to treat the PAIN.,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:48:13,1641516425,5/22/2015 18:47:26,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],TRIGEMINAL NEURALGIA bothered either PAIN.,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:49:11,1641517388,5/22/2015 18:48:39,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",recommended anyone with TRIGEMINAL NEURALGIA pain medicines used treat PAIN.,na,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:52:28,1641520700,5/22/2015 18:50:54,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[MANIFESTATION],[MANIFESTATION],is bothered either by the pain,none,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:54:52,1641523325,5/22/2015 18:52:42,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],used to treat the PAIN.,n/a,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 18:56:01,1641524293,5/22/2015 18:54:39,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],is bothered used to,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 19:01:20,1641530083,5/22/2015 19:01:10,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 19:12:20,1641543060,5/22/2015 19:12:06,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],treat,N/A,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993164,5/22/2015 19:32:53,1641579111,5/22/2015 19:32:31,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],who is bothered either by the pain,n/a,230,143,1,233,163,TWrex-cause,812853-FS1,"Because gamma knife radiosurgery works as well as the other procedures, but has the fewest risks, it can be recommended for almost anyone with TRIGEMINAL NEURALGIA who is bothered either by the pain or medicines used to treat the PAIN.",PAIN,TRIGEMINAL NEURALGIA
724993165,5/22/2015 17:17:02,1641437661,5/22/2015 17:16:43,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],used for,n/a,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:17:54,1641438136,5/22/2015 17:17:41,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],be used,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:21:08,1641440404,5/22/2015 17:20:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],should be used,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:21:32,1641440664,5/22/2015 17:20:58,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],440 Oral FLUCONAZOLE itraconazole should used for primary prophylaxis against COCCIDIOIDOMYCOSIS HIV infected adults adolescents.,n/a,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:21:52,1641440839,5/22/2015 17:21:32,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],OR,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:22:08,1641441000,5/22/2015 17:21:00,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],prophylaxis,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:22:09,1641441009,5/22/2015 17:21:17,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS] [OTHER],"[TREATS]
[OTHER]","FLUCONAZOLE OR ORAL itraconazole for prophylaxis against COC<span id=""transmark""></span>CIDIOIDOMYCOSIS",n/a,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:22:28,1641441181,5/22/2015 17:21:32,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:22:33,1641441244,5/22/2015 17:21:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],primary prophylaxis,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:33:29,1641446893,5/22/2015 17:32:55,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],should be used for primary prophylaxis against,N/a,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:34:56,1641447892,5/22/2015 17:34:36,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],should be used for primary prophylaxis,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:37:13,1641449641,5/22/2015 17:36:47,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],should be used for primary prophylaxis against,n/a,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:37:42,1641449816,5/22/2015 17:37:17,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],FLUCONAZOLE OR ORAL itraconazole should be used against COCCIDIOIDOMYCOSIS,na,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:40:05,1641451116,5/22/2015 17:39:11,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",should be used for,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993165,5/22/2015 17:47:10,1641455595,5/22/2015 17:46:37,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],against,N/A,91,11,-1,108,30,TWrex-cause,800710-FS1,440   Oral FLUCONAZOLE OR ORAL itraconazole should be used for primary prophylaxis against COCCIDIOIDOMYCOSIS in these HIV infected adults and adolescents.,COCCIDIOIDOMYCOSIS,FLUCONAZOLE OR ORAL
724993166,5/22/2015 16:42:22,1641413688,5/22/2015 16:42:08,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],presence.,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:46:40,1641416892,5/22/2015 16:45:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",n/a,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:47:19,1641417355,5/22/2015 16:47:01,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],initial clue,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:48:07,1641417870,5/22/2015 16:46:31,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",presence.,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:50:07,1641419513,5/22/2015 16:49:51,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],initial clue,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:52:14,1641421069,5/22/2015 16:51:26,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[SYMPTOM],[SYMPTOM],may be the initial clue,n/a,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:53:15,1641421649,5/22/2015 16:52:50,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],a,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:55:00,1641423004,5/22/2015 16:54:46,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],HYPERTENSION,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:56:31,1641423984,5/22/2015 16:56:15,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],pose,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 16:58:57,1641425794,5/22/2015 16:58:30,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[MANIFESTATION],[MANIFESTATION],may be the initial clue to their presence.,N/a,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 17:06:22,1641430150,5/22/2015 17:04:39,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],HYPERTENSION may be the initial clue to their presence.,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 17:06:55,1641430637,5/22/2015 17:06:36,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],clue to their presence.,N/A,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 17:10:40,1641433297,5/22/2015 17:09:33,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],pose,Ouslacrobbled,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 17:10:40,1641433317,5/22/2015 17:10:21,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],clue,n/a,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993166,5/22/2015 17:11:37,1641433894,5/22/2015 17:10:59,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],PHEOCHROMOCYTOMAS HYPERTENSION may be the initial clue to their presence.,n/a,56,2,1,67,19,TWrex-cause,812777-FS1,"• PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS
724993167,5/22/2015 17:26:49,1641443553,5/22/2015 17:26:39,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],characterized,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:38:22,1641450202,5/22/2015 17:37:00,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"characteristic OPTIC NERVE DAMAGE is a CHRONIC PROGRESSIVE OPTIC NEUR<span id=""transmark""></span>OPATHY",n/a,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:38:53,1641450388,5/22/2015 17:38:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],is a,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:39:53,1641451021,5/22/2015 17:39:41,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[MANIFESTATION],[MANIFESTATION],characterized,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:41:13,1641451881,5/22/2015 17:40:46,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[IS_A],[IS_A],is a,N/a,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:43:21,1641453503,5/22/2015 17:42:17,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",of,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:44:21,1641454079,5/22/2015 17:43:56,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is a,n/a,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:49:03,1641456769,5/22/2015 17:46:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],characteristic,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:49:48,1641457294,5/22/2015 17:49:31,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SYMPTOM],[SYMPTOM],OPTIC NERVE DAMAGE is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY,n/a,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:52:19,1641459159,5/22/2015 17:52:07,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CONTRAINDICATES],[CONTRAINDICATES],characterized,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:54:04,1641460536,5/22/2015 17:53:36,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",is a by of,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:55:29,1641461666,5/22/2015 17:54:43,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is a,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 17:59:17,1641465424,5/22/2015 17:59:02,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],visual field loss in the midperiphery.,n/a,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 18:07:48,1641473450,5/22/2015 18:07:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],OPTIC NERVE DAMAGE is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY,na,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993167,5/22/2015 18:08:01,1641473656,5/22/2015 18:07:26,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is a of,N/A,35,82,-1,52,118,TWrex-cause,802416-FS1,"Glaucoma  Glaucoma, characteristic OPTIC NERVE DAMAGE and visual field loss, is a CHRONIC PROGRESSIVE OPTIC NEUROPATHY   characterized by excavation of the optic nerve head and visual field loss in the midperiphery.",OPTIC NERVE DAMAGE,CHRONIC PROGRESSIVE OPTIC NEUROPATHY
724993168,5/22/2015 18:52:42,1641521026,5/22/2015 18:52:04,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with or or,N/A,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 18:56:10,1641524439,5/22/2015 18:55:29,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],CROHN'S DISEASE symptoms such as DIARRHEA,N/A,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 19:01:09,1641529853,5/22/2015 19:00:33,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]
[OTHER]",CROHN'S DISEASE patients atypical fissure symptoms DIARRHEA,na,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 19:04:31,1641533665,5/22/2015 19:04:18,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 19:08:19,1641538385,5/22/2015 19:07:31,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",associated with symptoms,N/A,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 19:37:36,1641584971,5/22/2015 19:37:17,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],symptoms,n/a,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 19:49:49,1641599953,5/22/2015 19:49:38,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],symptoms,n/a,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 20:00:22,1641614709,5/22/2015 19:57:56,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],atypical fissure,n/a,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 20:21:38,1641645897,5/22/2015 20:21:06,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [CONTRAINDICATES],"[SYMPTOM]
[MANIFESTATION]
[CONTRAINDICATES]",in patients with,N/A,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 20:21:46,1641646126,5/22/2015 20:21:31,false,neodev,1.0,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 20:37:27,1641667923,5/22/2015 20:37:01,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[SYMPTOM],[SYMPTOM],symptoms,N/A,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 20:54:10,1641686583,5/22/2015 20:52:32,false,clixsense,1.0,19294877,USA,MA,Boston,96.233.18.188,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Consider endoscopy investigate illnesses such as CROHN'S DISEASE in patients with DIARRHEA,n/a,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 21:04:29,1641696413,5/22/2015 21:04:14,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],symptoms,n/a,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 21:10:10,1641701250,5/22/2015 21:09:55,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],such,n/a,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993168,5/22/2015 21:30:28,1641720704,5/22/2015 21:30:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],symptoms such as,n/a,182,94,1,189,109,TWrex-cause,813989-FS1,"C]  Specific recommendation: • Consider endoscopy to investigate associated illnesses such as CROHN'S DISEASE only in patients with atypical fissure or other symptoms such as fever, DIARRHEA weight loss, or significant rectal bleeding.",DIARRHEA,CROHN'S DISEASE
724993169,5/22/2015 17:23:07,1641441547,5/22/2015 17:22:56,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:27:33,1641443925,5/22/2015 17:27:08,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],alVALPROIC ACID valproate and divalproex maintenance treatment BIPOLAR DISORDER,n/a,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:27:39,1641443998,5/22/2015 17:26:56,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:29:15,1641444809,5/22/2015 17:28:29,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"alVALPROIC ACID treatment of BIPOLAR DISOR<span id=""transmark""></span>DER",n/a,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:30:47,1641445279,5/22/2015 17:28:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:36:32,1641449137,5/22/2015 17:35:04,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:36:55,1641449495,5/22/2015 17:36:43,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:36:55,1641449498,5/22/2015 17:36:29,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],in the maintenance treatment of,N/a,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:41:11,1641451850,5/22/2015 17:40:57,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],alVALPROIC ACID in treatment of BIPOLAR DISORDER,n/a,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:41:38,1641452186,5/22/2015 17:41:16,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],maintenance treatment,n/a,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:47:18,1641455679,5/22/2015 17:45:55,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],in the maintenance treatment,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:49:27,1641457021,5/22/2015 17:49:08,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:49:47,1641457248,5/22/2015 17:49:35,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:57:14,1641463375,5/22/2015 17:57:01,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",valproate and divalproex in the maintenance treatment,n/a,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993169,5/22/2015 17:57:41,1641463792,5/22/2015 17:55:58,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alVALPROIC ACID in treatment of BIPOLAR DISORDER,na,111,40,-1,126,53,TWrex-cause,800714-FS1,"Macritchie KAN, Geddes JR, Scott J et alVALPROIC ACID valproate and divalproex in the maintenance treatment of BIPOLAR DISORDER (Cochrane Review.",BIPOLAR DISORDER,VALPROIC ACID
724993170,5/22/2015 16:40:30,1641412354,5/22/2015 16:40:12,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],Treatment,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:41:21,1641412928,5/22/2015 16:40:19,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",MYCOBACTERIAL INFECTIONS Treatment of infections caused by MYCOBACTERIUM ABSCESSUS + 157 or M. fortuitum + 157 used in conjunction with other antimycobacterial anti infectives.,n/a,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:42:50,1641414102,5/22/2015 16:41:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:42:53,1641414153,5/22/2015 16:42:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:44:26,1641415243,5/22/2015 16:43:56,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],caused by,n/a,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:47:30,1641417467,5/22/2015 16:47:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:49:27,1641418970,5/22/2015 16:48:30,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of caused by with,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:52:02,1641420983,5/22/2015 16:51:37,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[CAUSES],[CAUSES],infections caused by,N/a,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:52:48,1641421345,5/22/2015 16:52:16,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],infections,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:54:41,1641422754,5/22/2015 16:54:17,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],caused,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 16:57:19,1641424647,5/22/2015 16:56:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Treatment of infections,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 17:04:00,1641428717,5/22/2015 17:02:56,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 17:07:43,1641431184,5/22/2015 17:07:15,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment,n/a,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 17:09:10,1641432170,5/22/2015 17:07:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],infections caused by,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993170,5/22/2015 17:09:11,1641432182,5/22/2015 17:06:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,5,66,1,28,89,TWrex-cause,812539-FS1,100  MYCOBACTERIAL INFECTIONS  Treatment of infections caused by  MYCOBACTERIUM ABSCESSUS    +     157   or  M. fortuitum    +   ;  157   used in conjunction with other antimycobacterial anti infectives.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM ABSCESSUS
724993171,5/22/2015 18:28:16,1641495383,5/22/2015 18:27:35,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],RIBAVIRIN treatment CHRONIC HEPATITIS C:,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 18:38:15,1641506128,5/22/2015 18:38:03,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 18:50:44,1641519066,5/22/2015 18:50:04,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [TREATS] [PART_OF],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",with treatment of,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 18:54:16,1641522544,5/22/2015 18:53:43,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C:,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 18:59:20,1641527705,5/22/2015 18:58:48,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",RIBAVIRIN initial treatment CHRONIC HEPATITIS C:,na,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 19:03:44,1641532760,5/22/2015 19:03:33,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 19:05:57,1641535350,5/22/2015 19:05:26,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 19:36:45,1641583910,5/22/2015 19:36:29,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 19:46:21,1641595470,5/22/2015 19:46:08,false,bitcoinget,1.0,31947120,USA,CA,El Monte,198.101.125.188,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 19:49:04,1641598805,5/22/2015 19:48:47,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],for initial treatment of,n/a,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 19:54:50,1641606549,5/22/2015 19:54:16,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,n/a,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 20:17:44,1641640102,5/22/2015 20:17:26,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treatment of,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 20:20:59,1641644705,5/22/2015 20:20:48,false,neodev,1.0,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 20:29:22,1641657797,5/22/2015 20:27:33,false,elite,1.0,26544151,GBR,"","",31.103.92.118,[TREATS],[TREATS],RIBAVIRIN for initial treatment of CHRONIC HEPATITIS,n/a,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993171,5/22/2015 20:36:05,1641666394,5/22/2015 20:35:08,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[TREATS],[TREATS],treatment,N/A,153,118,-1,171,127,TWrex-cause,800639-FS1,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN
724993172,5/22/2015 16:40:09,1641412127,5/22/2015 16:39:55,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PART_OF],[PART_OF],of,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:40:18,1641412202,5/22/2015 16:39:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.,n/a,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:41:43,1641413180,5/22/2015 16:39:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment with,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:42:38,1641413963,5/22/2015 16:42:17,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:43:54,1641414840,5/22/2015 16:43:14,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],treatment with,n/a,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:47:11,1641417277,5/22/2015 16:46:23,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment with,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:48:26,1641418162,5/22/2015 16:47:34,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [IS_A] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",treatment with of a with,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:51:17,1641420376,5/22/2015 16:50:42,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],treatment with,N/a,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:52:15,1641421068,5/22/2015 16:51:52,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],pregnant,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:54:14,1641422415,5/22/2015 16:54:00,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[PART_OF],[PART_OF],of,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 16:56:18,1641423839,5/22/2015 16:55:09,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 17:02:13,1641427925,5/22/2015 17:00:56,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 17:06:53,1641430577,5/22/2015 17:05:45,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment with,N/A,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 17:07:14,1641430900,5/22/2015 17:06:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Emergency treatment,n/a,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993172,5/22/2015 17:10:58,1641433500,5/22/2015 17:10:12,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM,n/a,106,62,-1,123,102,TWrex-cause,803908-FS1,"Baudo F, Caimi TM, Redaelli R et al. Emergency treatment with RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR of PULMONARY EMBOLISM in a pregnant woman with antithrombin III deficiency.",PULMONARY EMBOLISM,RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR
724993173,5/22/2015 17:27:49,1641444070,5/22/2015 17:27:33,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnoses,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 17:40:36,1641451458,5/22/2015 17:40:24,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnoses,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 17:45:13,1641454539,5/22/2015 17:44:35,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 17:46:47,1641455396,5/22/2015 17:46:10,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 17:52:00,1641458916,5/22/2015 17:51:27,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[NONE],[NONE],n/a,"both are diseases, not related",122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 17:52:59,1641459609,5/22/2015 17:52:49,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnoses,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 17:55:23,1641461605,5/22/2015 17:55:01,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 17:57:48,1641463865,5/22/2015 17:56:59,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","are body dementia, frontotemporal dementia with",N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 18:00:04,1641466232,5/22/2015 17:59:48,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"ALZHEIMER DISEASE Lewy body dementia,",n/a,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 18:10:29,1641476177,5/22/2015 18:09:59,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",with of,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 18:11:09,1641476907,5/22/2015 18:10:19,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ALZHEIMER DISEASE with PARKINSONISM,na,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 18:12:35,1641478663,5/22/2015 18:11:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],The most common diagnoses,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 18:14:11,1641480462,5/22/2015 18:13:26,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],diagnoses,none,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 18:14:14,1641480541,5/22/2015 18:13:45,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM",N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993173,5/22/2015 18:17:23,1641483748,5/22/2015 18:16:07,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ALZHEIMER PARKINSONISM,N/A,122,55,1,133,72,TWrex-cause,814081-FS1,"The most common diagnoses in this clinical setting are ALZHEIMER DISEASE Lewy body dementia, frontotemporal dementia with PARKINSONISM and dementia of unknown etiology.",PARKINSONISM,ALZHEIMER DISEASE
724993174,5/22/2015 17:27:05,1641443742,5/22/2015 17:26:51,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:40:08,1641451156,5/22/2015 17:39:55,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SIDE_EFFECT],[SIDE_EFFECT],or,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:40:11,1641451212,5/22/2015 17:39:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",suggest,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:44:01,1641453929,5/22/2015 17:43:24,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by or,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:44:47,1641454370,5/22/2015 17:44:26,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggest,n/a,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:50:25,1641457559,5/22/2015 17:49:48,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[SYMPTOM],[SYMPTOM],ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS,n/a,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:51:35,1641458575,5/22/2015 17:49:04,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],suggest INFECTIOUS MONONUCLEOSIS,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:52:34,1641459304,5/22/2015 17:52:21,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:54:38,1641461045,5/22/2015 17:54:10,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by or or,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:56:14,1641462443,5/22/2015 17:55:37,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",suggest,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 17:59:34,1641465763,5/22/2015 17:59:17,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ADENOPATHY or hepatosplenomegaly suggest,n/a,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 18:08:39,1641474320,5/22/2015 18:08:05,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or or,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 18:09:40,1641475360,5/22/2015 18:07:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],ADENOPATHY suggest INFECTIOUS MONONUCLEOSIS,na,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 18:11:19,1641477129,5/22/2015 18:10:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],suggest,N/A,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993174,5/22/2015 18:12:57,1641479051,5/22/2015 18:12:18,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],suggest,none,202,243,1,211,267,TWrex-cause,813192-FS1,"Exudative pharyngitis, anterior cervical lymphadenopathy, and fever may be clinically indistinguishable from those caused by group A β hemolytic streptococci; however, posterior cervical or generalized ADENOPATHY or hepatosplenomegaly suggest INFECTIOUS MONONUCLEOSIS",ADENOPATHY,INFECTIOUS MONONUCLEOSIS
724993175,5/22/2015 17:57:18,1641463418,5/22/2015 17:57:06,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],plus,N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:02:45,1641468873,5/22/2015 18:02:24,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A],[IS_A],"A,",N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:20:00,1641486292,5/22/2015 18:19:25,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A],[IS_A],"A,",N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:20:27,1641486845,5/22/2015 18:19:54,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in,N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:21:36,1641488059,5/22/2015 18:21:07,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],INTERFERON ALPHA in RENAL CELL CARCINOMA,na,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:21:54,1641488304,5/22/2015 18:21:08,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[PART_OF],[PART_OF],INTERFERON ALPHA in RENAL CELL CARCINOMA,N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:27:18,1641494403,5/22/2015 18:25:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],in,none,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:31:04,1641498444,5/22/2015 18:30:22,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],interleukin 2 plus INTERFERON ALPHA,N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:37:32,1641505463,5/22/2015 18:37:10,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:39:44,1641507964,5/22/2015 18:39:03,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],INTERFERON ALPHA in RENAL,N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:41:12,1641509719,5/22/2015 18:40:52,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A],[IS_A],"A,",N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:43:11,1641512010,5/22/2015 18:41:54,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,no,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:44:23,1641512903,5/22/2015 18:43:43,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],INTERFERON ALPHA in RENAL CELL CARCINOMA,N/A,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:46:24,1641514931,5/22/2015 18:45:02,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PART_OF],[PART_OF],interferon in RENAL,n/a,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993175,5/22/2015 18:46:28,1641514967,5/22/2015 18:46:05,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",interferon INTERFERON ALPHA RENAL CELL CARCINOMA,na,118,98,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and interleukin 2 plus INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERFERON ALPHA
724993176,5/22/2015 17:17:52,1641438111,5/22/2015 17:17:42,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treat,n/a,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:22:08,1641441006,5/22/2015 17:21:55,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:24:29,1641442227,5/22/2015 17:23:57,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],PILOCARPINE prescribed treat XEROSTOMIA,n/a,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:24:32,1641442259,5/22/2015 17:24:04,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS],[TREATS],treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:25:31,1641442860,5/22/2015 17:24:57,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"PILOCARPINE treat XEROSTO<span id=""transmark""></span>MIA",n/a,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:26:13,1641443193,5/22/2015 17:25:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],to treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:26:13,1641443195,5/22/2015 17:25:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],PILOCARPINE may be prescribed to treat XEROSTOMIA,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:29:20,1641444849,5/22/2015 17:27:36,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:34:55,1641447878,5/22/2015 17:34:40,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],to treat,N/a,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:35:52,1641448548,5/22/2015 17:35:39,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:39:34,1641450830,5/22/2015 17:39:22,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],PILOCARPINE may treat XEROSTOMIA,n/a,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:39:48,1641450991,5/22/2015 17:39:05,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],prescribed to treat,n/a,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:42:56,1641453250,5/22/2015 17:42:26,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",prescribed to treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:43:34,1641453663,5/22/2015 17:43:24,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],to treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993176,5/22/2015 17:47:49,1641456058,5/22/2015 17:47:32,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS],[TREATS],treat,N/A,39,0,-1,48,11,TWrex-cause,804165-FS1,PILOCARPINE may be prescribed to treat XEROSTOMIA,XEROSTOMIA,PILOCARPINE
724993177,5/22/2015 18:22:51,1641489302,5/22/2015 18:22:15,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Decrease airway,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:23:14,1641489689,5/22/2015 18:22:49,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],CORTICOSTEROIDS Decrease airway INFLAMMATION,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:23:53,1641490507,5/22/2015 18:22:29,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [TREATS],"[TREATS]
[IS_A]",is a is a of of Treat,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:31:49,1641499259,5/22/2015 18:31:01,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],controller,none,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:32:49,1641500345,5/22/2015 18:32:26,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],Decrease airway INFLAMMATION,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:43:22,1641512161,5/22/2015 18:42:38,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [TREATS] [PART_OF],"[TREATS]
[IS_A]
[PART_OF]",is a is a of of Treat,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:44:48,1641513377,5/22/2015 18:42:53,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],Decrease airway INFLAMMATION,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:47:24,1641515817,5/22/2015 18:46:45,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CORTICOSTEROIDS (PREDNISOLONE) Decrease airway INFLAMMATION,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:48:35,1641516794,5/22/2015 18:47:49,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",CORTICOSTEROIDS (PREDNISOLONE) Decrease airway INFLAMMATION Varies dose noted,na,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:50:53,1641519199,5/22/2015 18:49:31,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],Decrease,none,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:52:41,1641521014,5/22/2015 18:51:36,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[SIDE_EFFECT],[SIDE_EFFECT],Decrease airway INFLAMMATION,n/a,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 18:54:35,1641522980,5/22/2015 18:53:45,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],Decrease,N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 19:01:06,1641529794,5/22/2015 19:00:52,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 19:12:03,1641542713,5/22/2015 19:11:47,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Salmeterol is a long acting controller medication,",N/A,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993177,5/22/2015 19:32:30,1641578503,5/22/2015 19:32:16,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],Decrease,n/a,267,219,-1,278,249,TWrex-cause,805212-FS1,"Salmeterol is a long acting controller medication, and albuterol is a quick reliever  Tachycardia, anxiety, theoretical hypertrophy of submucosal glands  Longitudinal studies of long acting b agonists are underway Oral CORTICOSTEROIDS (PREDNISOLONE)  Decrease airway INFLAMMATION  Varies 1 mg/kg po qod, dose noted in Cochrane review  Treat ABPA.",INFLAMMATION,CORTICOSTEROIDS (PREDNISOLONE)
724993178,5/22/2015 16:49:51,1641419343,5/22/2015 16:49:40,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],symptomatic,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 16:55:35,1641423402,5/22/2015 16:55:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],receiving moderate to high doses of,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 16:57:39,1641424864,5/22/2015 16:57:16,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],high doses of inhaled,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:05:12,1641429586,5/22/2015 17:04:49,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],symptomatic,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:06:05,1641429925,5/22/2015 17:05:07,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BECLOMETHASONE,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:06:14,1641430080,5/22/2015 17:04:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",CONCLUSIONS In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,n/a,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:06:17,1641430137,5/22/2015 17:05:40,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],doses,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:06:46,1641430496,5/22/2015 17:05:40,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with of of of of,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:13:09,1641434942,5/22/2015 17:12:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],receiving moderate to high doses,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:15:42,1641436707,5/22/2015 17:15:14,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],receiving,n/a,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:16:45,1641437477,5/22/2015 17:16:34,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],symptomatic,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:19:13,1641438983,5/22/2015 17:18:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],receiving moderate to high doses of,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:19:32,1641439227,5/22/2015 17:18:54,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of of of,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:19:35,1641439249,5/22/2015 17:18:32,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],receiving doses reduces,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993178,5/22/2015 17:20:16,1641439747,5/22/2015 17:18:51,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE,N/A,30,115,-1,43,129,TWrex-cause,804761-FS1,CONCLUSIONS  In patients with CHRONIC ASTHMA who are symptomatic while receiving moderate to high doses of inhaled BECLOMETHASONE the addition of 2 to 4 times the licensed dose of antileukotriene (AL) agents reduces the rate of exacerbations that require systemic corticosteroids.,CHRONIC ASTHMA,BECLOMETHASONE
724993179,5/22/2015 16:47:01,1641417165,5/22/2015 16:46:47,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 16:53:01,1641421495,5/22/2015 16:52:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 16:55:41,1641423509,5/22/2015 16:55:26,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment of,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 16:58:16,1641425364,5/22/2015 16:57:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS:,n/a,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 16:59:10,1641425937,5/22/2015 16:58:47,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 16:59:45,1641426329,5/22/2015 16:59:22,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:00:09,1641426578,5/22/2015 16:59:55,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:00:55,1641427131,5/22/2015 17:00:42,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ENDOMETRIOSIS:,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:10:11,1641432939,5/22/2015 17:09:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:13:26,1641435145,5/22/2015 17:13:17,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:13:53,1641435496,5/22/2015 17:13:39,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:15:10,1641436336,5/22/2015 17:14:44,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],(LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS:,n/a,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:15:20,1641436426,5/22/2015 17:14:34,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],the treatment,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:15:32,1641436575,5/22/2015 17:14:55,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],(LEUPROLIDE ACETATE in treatment of ENDOMETRIOSIS:,n/a,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993179,5/22/2015 17:15:58,1641436891,5/22/2015 17:14:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,113,52,-1,125,70,TWrex-cause,800361-FS1,"Dlugi AM, Miller JD, Knittle J et al. Lupron depot (LEUPROLIDE ACETATE for depot suspension) in the treatment of ENDOMETRIOSIS: a randomized, placebo controlled, double blind study.",ENDOMETRIOSIS,LEUPROLIDE ACETATE
724993180,5/22/2015 17:43:19,1641453474,5/22/2015 17:43:04,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[PART_OF],[PART_OF],had,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 17:54:04,1641460534,5/22/2015 17:53:17,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SIDE_EFFECT],[SIDE_EFFECT],third as many,n/a,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 17:56:34,1641462721,5/22/2015 17:56:18,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],third,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 17:58:42,1641464921,5/22/2015 17:58:28,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],WARFARIN STROKES,n/a,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:01:27,1641467522,5/22/2015 18:00:49,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[ASSOCIATED_WITH] [IS_A] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with with of a,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:11:20,1641477128,5/22/2015 18:10:13,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",significantly reduces the risk of stroke;,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:18:10,1641484505,5/22/2015 18:17:35,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with with,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:19:07,1641485467,5/22/2015 18:18:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],patients receiving,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:19:10,1641485544,5/22/2015 18:18:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],patients receiving WARFARIN a STROKES,na,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:20:16,1641486634,5/22/2015 18:19:42,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",patients receiving WARFARIN had a third as many STROKES,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:24:26,1641491176,5/22/2015 18:23:58,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],significantly reduces risk,none,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:29:33,1641496885,5/22/2015 18:29:01,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[PREVENTS],[PREVENTS],reduces the risk,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:33:37,1641501353,5/22/2015 18:32:59,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.112,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:39:48,1641508023,5/22/2015 18:37:25,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",with with a,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993180,5/22/2015 18:40:02,1641508370,5/22/2015 18:38:05,false,pocketmoneygpt,1,32162555,CAN,BC,Vancouver,108.180.194.80,[SIDE_EFFECT],[SIDE_EFFECT],patients receiving WARFARIN had a third as many STROKES,N/A,179,150,-1,185,158,TWrex-cause,805135-FS1,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN
724993181,5/22/2015 16:44:46,1641415497,5/22/2015 16:44:27,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],infect,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 16:51:23,1641420383,5/22/2015 16:50:47,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],can infect,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 16:53:54,1641422179,5/22/2015 16:53:25,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],"can infect humans,",N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 16:54:30,1641422610,5/22/2015 16:53:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"ZOONOTIC POXVIRUS INFECTIONS IN HUMANS Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",n/a,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 16:55:19,1641423183,5/22/2015 16:52:26,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],including,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 16:57:11,1641424561,5/22/2015 16:56:37,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",OF with of,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 16:58:34,1641425589,5/22/2015 16:58:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],human infections,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 16:59:10,1641425931,5/22/2015 16:58:57,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CAUSES],[CAUSES],infect,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 17:09:06,1641432106,5/22/2015 17:08:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],infect,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 17:12:26,1641434502,5/22/2015 17:12:16,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],can infect,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 17:12:27,1641434524,5/22/2015 17:12:08,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],including,n/a,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 17:12:41,1641434677,5/22/2015 17:12:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"71,72 ZOONOTIC POXVIRUS INFECTIONS IN HUMANS Several POXVIRUSES OF ANIMALS can infect humans,",n/a,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 17:12:52,1641434748,5/22/2015 17:12:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",OF with of or,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 17:13:41,1641435320,5/22/2015 17:12:28,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],POXVIRUS INFECTIONS IN HUMANS Several POXVIRUSES OF ANIMALS,N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993181,5/22/2015 17:13:47,1641435414,5/22/2015 17:12:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"can infect humans, including",N/A,7,55,1,34,76,TWrex-cause,811252-FS1,"71,72  ZOONOTIC POXVIRUS INFECTIONS IN HUMANS  Several POXVIRUSES OF ANIMALS can infect humans, including paravaccinia, orf, monkeypox, and tanapox; human infections result from direct contact with natural animal reservoirs of these agents or arthropod vectors, and humans are only incidental hosts.",ZOONOTIC POXVIRUS INFECTIONS,POXVIRUSES OF ANIMALS
724993182,5/22/2015 17:17:25,1641437819,5/22/2015 17:17:15,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:18:55,1641438802,5/22/2015 17:18:08,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:21:34,1641440669,5/22/2015 17:21:23,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:22:47,1641441377,5/22/2015 17:22:28,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],alAMOXYCILLIN and clavulanic acid treatment of URINARY INFECTION,n/a,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:23:04,1641441530,5/22/2015 17:22:49,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:23:30,1641441741,5/22/2015 17:22:47,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],alAMOXYCILLIN treatment of URINARY INFECTION,n/a,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:23:33,1641441794,5/22/2015 17:23:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:24:05,1641442134,5/22/2015 17:23:31,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],in the treatment,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:26:00,1641443121,5/22/2015 17:24:52,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:34:12,1641447357,5/22/2015 17:33:53,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],in the treatment,N/a,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:35:24,1641448166,5/22/2015 17:35:13,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:38:15,1641450128,5/22/2015 17:37:58,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treatment,n/a,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:38:41,1641450234,5/22/2015 17:38:12,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],alAMOXYCILLIN in the treatment of URINARY INFECTION,n/a,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:41:49,1641452293,5/22/2015 17:41:13,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],in the treatment,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993182,5/22/2015 17:42:57,1641453251,5/22/2015 17:42:39,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],in the treatment of,N/A,92,40,-1,108,51,TWrex-cause,800684-FS1,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN
724993183,5/22/2015 18:22:11,1641488657,5/22/2015 18:21:19,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SIDE_EFFECT],[SIDE_EFFECT],"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, after",N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:22:26,1641488955,5/22/2015 18:21:19,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",A of,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:22:48,1641489266,5/22/2015 18:22:32,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],ASTHMATICS after SALBUTAMOL,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:30:51,1641498194,5/22/2015 18:29:24,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],after,none,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:32:23,1641499912,5/22/2015 18:32:03,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],after,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:42:34,1641511242,5/22/2015 18:42:05,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A],[IS_A],A,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:42:52,1641511603,5/22/2015 18:40:55,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[MANIFESTATION],[MANIFESTATION],expiratory flows and arterial blood gas after SALBUTAMOL,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:46:44,1641515259,5/22/2015 18:45:54,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ASTHMATICS after SALBUTAMOL,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:47:47,1641516146,5/22/2015 18:47:28,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",ASTHMATICS bronchitis after SALBUTAMOL ipratropin.,na,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:49:28,1641517656,5/22/2015 18:47:27,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[CAUSES],[CAUSES],after,none,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:51:35,1641519849,5/22/2015 18:48:59,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],after SALBUTAMOL and ipratropin.,n/a,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 18:53:41,1641521895,5/22/2015 18:52:30,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],after,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 19:00:48,1641529411,5/22/2015 19:00:34,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 19:11:45,1641542339,5/22/2015 19:11:35,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],double blind cross,N/A,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993183,5/22/2015 19:32:14,1641578175,5/22/2015 19:31:50,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],after,n/a,104,136,-1,113,146,TWrex-cause,804248-FS1,"A double blind cross over study of maximal expiratory flows and arterial blood gas tensions in normals, ASTHMATICS and bronchitis after SALBUTAMOL and ipratropin.",ASTHMATICS,SALBUTAMOL
724993184,5/22/2015 17:22:39,1641441281,5/22/2015 17:22:26,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],prevent,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:26:07,1641443152,5/22/2015 17:25:37,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",Rewarming hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,n/a,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:26:11,1641443163,5/22/2015 17:25:24,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by of,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:27:17,1641443779,5/22/2015 17:26:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],failure to prevent,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:27:22,1641443803,5/22/2015 17:26:18,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[OTHER],[OTHER],"failure of HEPARIN to prevent D<span id=""transmark""></span>IC",n/a,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:33:52,1641447118,5/22/2015 17:31:25,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],failure of HEPARIN to prevent,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:35:43,1641448479,5/22/2015 17:35:18,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[CONTRAINDICATES],[CONTRAINDICATES],failure of HEPARIN to prevent DIC,N/a,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:36:28,1641449090,5/22/2015 17:36:17,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[PREVENTS],[PREVENTS],prevent,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:40:30,1641451418,5/22/2015 17:39:48,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[PREVENTS],[PREVENTS],HEPARIN to prevent DIC,n/a,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:40:48,1641451586,5/22/2015 17:40:16,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[PREVENTS],[PREVENTS],prevent,n/a,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:44:29,1641454222,5/22/2015 17:43:46,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[PREVENTS],[PREVENTS],to prevent,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:48:41,1641456551,5/22/2015 17:48:21,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by of,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:49:20,1641456965,5/22/2015 17:49:08,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],prevent,N/A,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:53:46,1641460279,5/22/2015 17:53:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],HEPARIN to prevent DIC,na,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993184,5/22/2015 17:54:14,1641460634,5/22/2015 17:53:36,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",failure of HEPARIN to prevent DIC,n/a,73,54,1,75,61,TWrex-cause,812345-FS1,Rewarming by hemodialysis for hypothermia: failure of HEPARIN to prevent DIC,DIC,HEPARIN
724993185,5/22/2015 16:47:33,1641417482,5/22/2015 16:47:19,false,elite,1,31227441,USA,IL,Chicago,173.193.202.116,[PART_OF],[PART_OF],and/or,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 16:53:52,1641422118,5/22/2015 16:53:25,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],are seen in,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 16:56:20,1641423869,5/22/2015 16:55:55,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],are seen in patients,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:00:15,1641426649,5/22/2015 16:58:58,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],"A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin",n/a,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:00:19,1641426761,5/22/2015 16:59:39,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",A or with with of,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:01:23,1641427496,5/22/2015 17:00:56,false,elite,1,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],patients with,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:02:09,1641427885,5/22/2015 17:00:13,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",seen in,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:02:26,1641428089,5/22/2015 17:01:36,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ALBRIGHT SYNDROME,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:11:25,1641433768,5/22/2015 17:11:11,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],are seen in,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:13:59,1641435563,5/22/2015 17:13:44,false,elite,1,30654968,USA,OR,Portland,67.213.218.73,[OTHER],[OTHER],are,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:14:31,1641435870,5/22/2015 17:14:10,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are seen,n/a,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:17:07,1641437691,5/22/2015 17:16:12,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are seen patients with HYPERCORTISOLISM,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:17:09,1641437703,5/22/2015 17:15:42,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]","unilateral mass (adenoma carcinoma) contralateral atrophy, bilateral masses small and/or glands",n/a,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:17:11,1641437723,5/22/2015 17:15:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],seen in patients with,N/A,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993185,5/22/2015 17:17:26,1641437850,5/22/2015 17:16:14,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SYMPTOM],[SYMPTOM],"(MCCUNE ALBRIGHT SYNDROME seen in patients with HYPE<span id=""transmark""></span>RCORTISOLISM",n/a,291,99,1,306,123,TWrex-cause,812620-FS1,"Evidence: • A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME
724993186,5/22/2015 17:22:23,1641441142,5/22/2015 17:22:13,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:25:14,1641442643,5/22/2015 17:24:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",treatment of with,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:25:18,1641442719,5/22/2015 17:24:40,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],alSERTRALINE treatment children adolescents with OBSESSIVE COMPULSIVE DISORDER depression.,n/a,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:26:13,1641443201,5/22/2015 17:25:42,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"alSERTRALINE treatment of OBSESSIVE COMPULSIVE DISORDE<span id=""transmark""></span>R",n/a,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:26:37,1641443414,5/22/2015 17:26:19,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:27:12,1641443772,5/22/2015 17:26:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:31:08,1641445460,5/22/2015 17:29:26,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:35:17,1641448091,5/22/2015 17:34:56,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],treatment of,N/a,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:36:11,1641448721,5/22/2015 17:35:56,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:39:48,1641450987,5/22/2015 17:39:36,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],alSERTRALINE treatment of children with OBSESSIVE COMPULSIVE DISORDER,n/a,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:40:15,1641451252,5/22/2015 17:39:48,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treatment of children and adolescents,n/a,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:43:43,1641453751,5/22/2015 17:43:00,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],treatment of children and adolescents with,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:48:17,1641456361,5/22/2015 17:47:53,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [PART_OF] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",treatment of with or,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:49:07,1641456788,5/22/2015 17:48:54,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993186,5/22/2015 17:53:04,1641459704,5/22/2015 17:52:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alSERTRALINE treatment of OBSESSIVE COMPULSIVE DISORDER,na,92,38,-1,120,48,TWrex-cause,800366-FS1,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE
724993187,5/22/2015 17:23:24,1641441705,5/22/2015 17:23:10,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],inhibitor,N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:28:26,1641444384,5/22/2015 17:27:46,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",an of with or,N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:28:32,1641444440,5/22/2015 17:27:40,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, patients AIDS AIDS related complex.",n/a,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:30:50,1641445304,5/22/2015 17:29:23,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[OTHER],[OTHER],"inhibitor of HTLV III/LAV replication, to patients with AI<span id=""transmark""></span>DS",n/a,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:33:30,1641446895,5/22/2015 17:31:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],Administration of,N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:37:11,1641449629,5/22/2015 17:36:57,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],related,N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:37:33,1641449801,5/22/2015 17:36:56,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[PART_OF],[PART_OF],"an inhibitor of HTLV III/LAV replication, to patients with AIDS",N/a,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:38:09,1641450072,5/22/2015 17:36:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],to patients with,N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:41:56,1641452403,5/22/2015 17:41:11,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[PREVENTS],[PREVENTS],HTLV III/LAV with AIDS,n/a,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:42:03,1641452509,5/22/2015 17:41:40,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[CONTRAINDICATES],[CONTRAINDICATES],"inhibitor replication,",n/a,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:48:40,1641456529,5/22/2015 17:47:30,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","replication, to patients with",N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:50:02,1641457505,5/22/2015 17:49:48,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],inhibitor,N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:50:42,1641457737,5/22/2015 17:49:31,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[IS_A] [ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",an of with or,N/A,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:57:28,1641463536,5/22/2015 17:57:15,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",to patients with AIDS or AIDS,n/a,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993187,5/22/2015 17:58:31,1641464576,5/22/2015 17:57:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],inhibitor of HTLV III/LAV to patients with AIDS,na,147,104,1,150,116,TWrex-cause,812467-FS1,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV
724993188,5/22/2015 17:28:35,1641444454,5/22/2015 17:28:17,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevent treat,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 17:41:05,1641451790,5/22/2015 17:40:54,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug used,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 17:48:29,1641456464,5/22/2015 17:47:25,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevent treat,n/a,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 17:53:43,1641460171,5/22/2015 17:52:22,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",DROPERIDOL prevent and treat nausea and VOMITING;,n/a,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 17:53:53,1641460380,5/22/2015 17:53:38,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug used,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 17:56:23,1641462572,5/22/2015 17:55:56,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",drug treat,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 17:59:15,1641465398,5/22/2015 17:58:38,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevent and treat,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:01:33,1641467669,5/22/2015 18:00:54,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to prevent and treat nausea,n/a,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:11:35,1641477382,5/22/2015 18:11:03,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",A drug treat,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:12:13,1641478209,5/22/2015 18:11:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",DROPERIDOL prevent and treat VOMITING;,na,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:13:44,1641479904,5/22/2015 18:13:02,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS] [PREVENTS] [OTHER],"[TREATS]
[PREVENTS]
[OTHER]",to prevent and treat,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:15:04,1641481356,5/22/2015 18:14:35,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.158.78,[TREATS],[TREATS],DROPERIDOL treat nausea and VOMITING;,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:15:16,1641481474,5/22/2015 18:14:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",prevent treat,none,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:24:46,1641491509,5/22/2015 18:24:24,false,prodege,1.0,1924522,USA,NY,New York,96.224.13.217,[TREATS],[TREATS],DROPERIDOL,N/A,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993188,5/22/2015 18:27:44,1641494877,5/22/2015 18:27:11,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],to prevent and treat nausea and VOMITING;,n/a,142,0,-1,149,10,TWrex-cause,804646-FS1,DROPERIDOL    (                 audio )  A drug used for three purposes: to premedicate patients for surgery; to prevent and treat nausea and VOMITING; and to sedate agitated and psychotic patients.,VOMITING,DROPERIDOL
724993189,5/22/2015 17:23:42,1641441893,5/22/2015 17:23:31,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:29:22,1641444873,5/22/2015 17:28:35,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:29:27,1641444933,5/22/2015 17:28:45,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],alTERBINAFINE treatment of TRICHOPHYTON TINEA CAPITIS:,n/a,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:31:47,1641445909,5/22/2015 17:31:01,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"alTERBINAFINE treatment of TRICHOPHYTON TINEA CAPI<span id=""transmark""></span>TIS:",n/a,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:34:08,1641447294,5/22/2015 17:33:34,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:37:27,1641449747,5/22/2015 17:37:13,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:37:53,1641449870,5/22/2015 17:37:35,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],in the treatment of,N/a,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:39:24,1641450729,5/22/2015 17:38:14,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:42:32,1641452881,5/22/2015 17:42:04,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],treatment,n/a,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:42:40,1641453014,5/22/2015 17:41:57,false,instagc,1.0,31184650,USA,IA,West Des Moines,63.153.203.116,[TREATS],[TREATS],alTERBINAFINE in treatment of TRICHOPHYTON TINEA CAPITIS:,n/a,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:49:38,1641457152,5/22/2015 17:48:56,false,neodev,1.0,31294288,USA,IL,Chicago,67.212.188.11,[TREATS],[TREATS],in the treatment of,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:50:42,1641457723,5/22/2015 17:50:23,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:51:22,1641458338,5/22/2015 17:50:56,false,neodev,1.0,28630436,USA,DE,Wilmington,162.223.93.178,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 17:57:41,1641463791,5/22/2015 17:57:29,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",treatment of TRICHOPHYTON TINEA CAPITIS:,n/a,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993189,5/22/2015 18:00:16,1641466374,5/22/2015 17:58:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],alTERBINAFINE in treatment of TRICHOPHYTON TINEA CAPITIS:,na,71,39,-1,96,50,TWrex-cause,800686-FS1,"Friedlander SF, Aly R, Krafchik B et alTERBINAFINE in the treatment of TRICHOPHYTON TINEA CAPITIS: a randomized, double blind, parallel group, duration finding study.",TRICHOPHYTON TINEA CAPITIS,TERBINAFINE
724993190,5/22/2015 16:44:24,1641415231,5/22/2015 16:44:00,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],resulting,N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:50:45,1641420075,5/22/2015 16:50:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],resulting in,N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:52:25,1641421167,5/22/2015 16:50:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[LOCATION],[LOCATION],"branches,",N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:53:19,1641421699,5/22/2015 16:52:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Complications As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",n/a,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:53:23,1641421758,5/22/2015 16:53:01,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],resulting in,N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:56:20,1641423862,5/22/2015 16:55:28,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],resulting in,n/a,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:56:31,1641424012,5/22/2015 16:56:04,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],is,N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:58:11,1641425278,5/22/2015 16:57:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],FACIAL PARALYSIS,N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 16:58:55,1641425790,5/22/2015 16:58:43,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],"affected,",N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 17:08:48,1641431887,5/22/2015 17:08:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],"may be affected,",N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 17:12:07,1641434245,5/22/2015 17:11:51,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],resulting,n/a,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 17:12:13,1641434336,5/22/2015 17:12:04,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],"affected,",N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 17:12:26,1641434495,5/22/2015 17:11:42,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],"FACIAL NERVE and the nerve, may be affected, resulting in FACIAL PARALYSIS",N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 17:12:54,1641434763,5/22/2015 17:11:57,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [SYMPTOM] [OTHER],"[SYMPTOM]
[ASSOCIATED_WITH]
[OTHER]","FACIAL NERVE may be affected, resulting in FACIAL PAR<span id=""transmark""></span>ALYSIS",n/a,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993190,5/22/2015 17:13:09,1641434917,5/22/2015 17:11:54,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],resulting in,N/A,137,201,-1,148,217,TWrex-cause,802623-FS1,"edit] Complications  As the skull base is progressively involved, the adjacent exiting cranial nerves and their branches, especially the FACIAL NERVE and the vagus nerve, may be affected, resulting in FACIAL PARALYSIS and hoarseness, respectively.",FACIAL NERVE,FACIAL PARALYSIS
724993191,5/22/2015 16:41:18,1641412871,5/22/2015 16:41:05,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PART_OF],[PART_OF],Included,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:43:48,1641414803,5/22/2015 16:42:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","REVIEW SCOPE Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",n/a,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:44:51,1641415552,5/22/2015 16:44:29,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:45:25,1641415958,5/22/2015 16:44:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],studies,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:48:21,1641418075,5/22/2015 16:47:29,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],in each treatment group.,m/a,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:48:57,1641418591,5/22/2015 16:48:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:51:35,1641420599,5/22/2015 16:50:53,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",or a of of drugs with or with of treatment,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:54:01,1641422270,5/22/2015 16:53:28,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],OSTEOARTHRITIS,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:54:27,1641422582,5/22/2015 16:54:00,false,instagc,1.0,24252915,GBR,K6,Southsea,80.44.194.25,[TREATS],[TREATS],treatment group.,N/a,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 16:55:31,1641423374,5/22/2015 16:55:16,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drugs,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 17:00:18,1641426741,5/22/2015 16:59:06,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],combination of 2 of the drugs with each other,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 17:05:49,1641429831,5/22/2015 17:05:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 17:08:55,1641431953,5/22/2015 17:08:41,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],combination,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 17:10:18,1641433027,5/22/2015 17:09:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993191,5/22/2015 17:11:07,1641433629,5/22/2015 17:09:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],studies combination of 2 of the drugs,N/A,203,88,-1,216,107,TWrex-cause,800841-FS1,"REVIEW SCOPE  Included studies compared glucosamine sulfate, glucosamine hydrochloride, CHONDROITIN SULFATE or a combination of 2 of the drugs with each other or placebo and included ≥ 100 patients with OSTEOARTHRITIS of the hip or knee in each treatment group.",OSTEOARTHRITIS,CHONDROITIN SULFATE
724993192,5/22/2015 18:51:01,1641519320,5/22/2015 18:50:47,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",caused by,N/A,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 18:54:43,1641523117,5/22/2015 18:54:17,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],MALARIA caused by PLASMODIUM VIVAX.,N/A,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 18:59:49,1641528229,5/22/2015 18:59:23,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER] [ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]
[OTHER]",MALARIA caused PLASMODIUM VIVAX.,na,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 19:03:58,1641533073,5/22/2015 19:03:47,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.137,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 19:06:35,1641536137,5/22/2015 19:06:01,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 19:36:58,1641584139,5/22/2015 19:36:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 19:46:31,1641595673,5/22/2015 19:46:22,false,bitcoinget,1.0,31947120,USA,CA,El Monte,198.101.125.188,[CAUSES],[CAUSES],caused,N/A,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 19:49:18,1641599084,5/22/2015 19:49:08,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],caused by,n/a,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 19:56:02,1641608457,5/22/2015 19:54:56,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],caused,n/a,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 20:20:24,1641643905,5/22/2015 20:17:46,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],caused by,N/A,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 20:21:16,1641645240,5/22/2015 20:21:02,false,neodev,1.0,32681906,USA,IL,Chicago,65.60.20.66,[NONE],[NONE],none,none,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 20:30:20,1641659273,5/22/2015 20:29:25,false,elite,1,26544151,GBR,"","",31.103.92.118,[CAUSES] [MANIFESTATION] [SYMPTOM] [PART_OF],"[CAUSES]
[SYMPTOM]
[MANIFESTATION]
[PART_OF]",MALARIA caused by PLASMODIUM VIVAX.,n/a,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 20:36:26,1641666707,5/22/2015 20:36:06,false,instagc,1.0,19602039,USA,WA,Bellevue,50.135.214.140,[CAUSES],[CAUSES],caused,N/A,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 20:49:31,1641681529,5/22/2015 20:48:31,false,clixsense,1.0,19294877,USA,MA,Boston,96.233.18.188,[CAUSES],[CAUSES],MALARIA caused by PLASMODIUM VIVAX.,n/a,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
724993192,5/22/2015 21:03:49,1641695810,5/22/2015 21:02:48,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,0,19,1,6,35,TWrex-cause,811017-FS1,MALARIA caused by  PLASMODIUM VIVAX.,MALARIA,PLASMODIUM VIVAX
